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ABSTRACT 
While early studies of normal aging largely focused on the loss of neurons 
as a basis of cognitive aging, current studies of both aging humans and the 
rhesus monkey model of normal aging demonstrate that forebrain neurons are 
largely preserved. Instead, MRI and electron microscopic analyses show that 
age-related changes in the white matter are good predictors of cognitive 
impairment. White matter changes include an increase in damaged myelin 
sheaths as well as a loss of myelinated fibers. To explore potential causes of the 
white matter alterations, the expression of genes related to myelination and 
axonal survival were examined revealing age-related alterations in the 
expression of 9 genes in grey matter and 7 in subcortical white matter of the 
inferior parietal lobule (IPL). Four were selected for further analysis. Of these, 
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brain-derived neurotrophic factor (BDNF) had a statistically significant decrease 
in expression in the cortical grey matter of the IPL at both the level of gene 
expression and of protein expression. In 27 male and female rhesus monkeys 
ranging from young to old, the precursor form of BDNF (proBDNF) was 
significantly decreased while the mature form was preserved. In order to 
understand the localization of the age-related decline in proBDNF, 
immunohistochemical reactivity was quantified in the IPL and in the 
hippocampus. In the IPL there was a significant decrease in total 
immunohistochemical reactivity. Further analysis showed that there was an 
increase in the number of proBDNF positive somata while there was no change 
in the smaller extrasomal puncta. This increase in cell bodies expressing 
proBDNF despite the age-related decrease in total proBDNF 
immunohistochemical density suggests disruption of post-translational 
processing and/or transport out into the processes. In contrast to the IPL, there 
was no change in proBDNF density in the hippocampus with age. However, in 
the hippocampus but not the IPL, proBDNF immunohistochemical reactivity was 
sexually dimorphic with higher levels in the female monkeys compared to males. 
While the significance of the change in proBDNF levels for myelin damage is 
unclear, alteration in this neurotrophin may play a role in the axon loss that 
accompanies myelin degradation. 
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CHAPTER I 
INTRODUCTION 
1 
Age Dependent Cognitive Impairment 
An understanding of normal aging is important for the health and well 
being of the population as the number of people over the age of 65 is increasing 
with the post World War II "baby boomer" population reaching 65 years of age 
starting in 2011. In 2010, about 11 percent of the world population was over the 
age of 60 (United Nations et al., 2011) and 13 percent of the population of the 
United States was older than 65 (Werner, 2011) but those numbers are expected 
to expand to approximately 22 percent of the total population in the world (United 
Nations ·et al., 2011) and 20.2 percent in the United States by 2050 (Vincent and 
Velkoff, 2010). In parallel with the increasing number of elderly, the life 
expectancy at birth in the United States has been steadily increasing from 47.3 in 
1900 to 75.4 in 1990 to 76.9 years in 2000 and finally to 78.2 in 2009 (He et al., 
2005; Kochanek et al., 2011 ). While many different physiological processes 
decline in normal aging, impairments in cognitive abilities lead to a significant 
decrease in the quality of life and puts individuals at greater risk for the 
development of dementias (Ritchie et al. , 2001; Busse et al., 2003). 
The changes in cognition that are seen in normal aging affect many 
different cognitive domains including learning, memory and executive function 
(Albert, 1988; 1993). The alteration in cognitive domains does not happen 
simultaneously but instead the different domains are affected at various ages. In 
humans, memory is affected first, beginning by the age of 50 when the ability to 
recall large amounts of information after a long delay is impaired (Albert, 1988). 
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The cause of the memory deficits is believed to be a change in the encoding and 
recall of the information rather than the loss of memory storage capacity with age 
(Albert, 1988). In contrast to memory, loss of executive function is correlated 
with age but the largest differences are not seen until around age 70 (Haaland et 
al., 1987; Albert, 1988; 1993; Gunning-Dixon and Raz, 2003). This executive 
function deficit is seen as an increase in perseverative errors as the cognitive 
flexibility necessary to allow task or rule changes is lost (Figurov et al., 1996; 
Pang et al., 2004; Woo et al., 2005; Danzer and McNamara, 2004; Band et al., 
2002; Ridderinkhof et al., 2002). While these functional changes in learning, 
memory and executive function with age have been well described, the cause of 
these changes is largely unknown. 
Cortical Neuron Preservation 
The search for the substrate of age-related cognitive decline began by 
looking at cortical neuronal loss as a likely contributor. Early studies seemed to 
back up the assertion that neurons are lost with age by finding changes in 
neuronal density in many brain areas, but the magnitude of neuronal loss was 
region specific (Brody, 1955; 1970). Losses of up to 50% of neurons from age 
18 to 95 years old were found in the superior frontal gyrus and superior temporal 
gyrus, while more moderate losses of 20-30% of neurons were observed in the 
precentral gyrus and the visual cortex (Brody, 1955; 1970). Several others 
studies in the 1970's and 1980's supported these results in both humans (Shefer, 
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1973; Anderson et al., 1983) and non-human primates (Brizzee et al., 1975b; 
1980). 
However, with the introduction of cell counting methods using design 
based stereology and other techniques, the question of cell loss during aging 
was re-examined. In 1985, Haug found no significant decreases in cortical 
neuronal numbers with age in a large sample of 120 human brains. It was also 
noted that there were differences in the shrinkage of young and old brains of up 
to 15% during standard immersion fixation and histological processing of human 
tissue, suggesting that the contradiction of previous results could be explained by 
the effect on neuron packing density (Haug, 1985). More recent studies looking 
at neuron number with age in humans (Terry et al., 1987; Pakkenberg and 
Gundersen, 1997; Freeman et al., 2008) and non-human primates (Vincent et al., 
1989; Tigges et al., 1990; Peters et al., 1994; 1997b; Merrill et al., 2000; Keuker 
et al., 2003; Giannaris and Rosene, 2012; Roberts et al., 2012) have supported 
Haug's data and the notion that neuron number is largely preserved with normal 
aging. One study has pointed to a focal loss of neurons in area 8A of the 
prefrontal cortex while preserving neuronal numbers in the adjacent cortex, area 
46 (Smith et al., 1999) raising the possibility that there are focal changes in 
neuron numbers that have been missed when looking at whole brains or at 
limited cortical regions. However, this result was not replicated in an 
independent sample of rhesus monkey brains in this laboratory (Unpublished 
data). 
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While there do not seem to be major changes in the number of neurons in 
the cortex with age, there are several changes in the structure of neurons that 
may have an effect on their function. The soma of neurons undergoes shrinkage 
(Cacquevel et al., 2007; Terry et al., 1987; Tigges et al., 1990) and accumulation 
of lipofuscin granules (Brizzee et al., 1975a; Tigges et al., 1990; Peters et al., 
1994 ). In addition to the changes of the soma, the dendritic tree undergoes 
pruning (Cupp and Uemura, 1980; Luebke and Rosene, 2003; Dickstein et al., 
2007), spine density decreases in both the apical and basal trees (Dickstein et 
al., 2007; 2012; Duan, 2003), and decreased synaptic density (Peters et al., 
1998; 2008). 
In addition to these morphological changes, there are also changes in 
several electrophysiological parameters in the pyramidal cells in layer Ill of the 
prefrontal cortex including decreased synaptic excitation, increased inhibition and 
increased amplitude of the slow after-hyperpolarization current (siAHP) (Luebke 
and Rosene, 2003; Luebke et al., 2004; Chang et al., 2005; Luebke et al., 201 0; 
Luebke and Amatrudo, 2012). In contrast, the intrinsic electrophysiological 
parameters are largely unchanged in the layer V pyramidal neurons in area 46 
(Luebke and Chang, 2007) suggesting that the corticocortical projecting neurons 
of layer Ill are more affected by aging than the subcortically projecting neurons of 
layer V. There is also a change in the cortical organization of the neurons in 
layer Ill of area 46 as measured by a decrease in the strength of cortical 
microcolumns with age (Cruz et al., 2004; 2009). Many of these sublethal 
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changes in neuronal properties (Morrison and Hof, 1997) affect the function of 
the neurons and correlate with cognitive performance. 
White Matter Integrity 
In contrast to the preservation of cortical neurons, investigation of the 
white matter reveals a number of profound changes in normal aging. Histological 
changes in white matter were originally described as an increased pallor when 
examining myelin fiber staining (Lintl and Braak, 1983; Kemper, 1994 ). The 
change in white matter pallor appears to be regionally specific with the areas that 
finish myelination first, the primary cortices, relatively spared, while the regions 
that undergo myelination last, association and limbic cortices, have the largest 
loss in myelin (Kemper, 1994 ). Quantification of myelin in the line of Gennari in 
the human visual cortex shows that the loss of myelin begins as early as age 30 
(Lintl and Braak, 1983). 
Electron microscopic studies were conducted to gain a better 
understanding of whether the decreased myelin staining reflects a loss of axons 
or demyelination of axons or both. These studies have been done in rhesus 
monkey brains since the optimal preservation of the tissue allows for better 
ultrastructual analysis compared to human autopsy samples. Degeneration of 
the myelin sheaths was observed as either a splitting of the sheath along the 
major dense line with the incorporation of dense cytoplasm from the 
oligodendrocyte (Peters et al., 2000; Sandell and Peters, 2001) or the splitting of 
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the myelin sheath along the intraperiod line (i.e. the extracellular membrane 
faces) with the formation of fluid filled balloons (Feldman and Peters, 1998; 
Peters and Sethares, 2002). 
In addition to the myelin sheath damage, there is considerable evidence of 
remyelination in the aging brain. There are increased numbers of paranodes 
with age (Peters and Sethares, 2003), an indication that the length of the 
interperiod myelin sheath is decreasing with age (and nodes are closer), along 
with a molecular reorganization of sodium and potassium channels at the nodes 
of Ranvier (Hinman et al., 2006). Also, while the number of lamellae of myelin 
surrounding an axon increases with age (Peters et al., 2001) suggesting a 
possible dysregulation of myelin formation by oligodendroglia, there is also an 
increase in the number of profiles of axons with myelin sheaths too thin for the 
size of the axon (Peters and Sethares, 2003), suggesting that many may be in 
early stages of remyelination. There is also an increase in redundant myelin 
sheaths, where the myelin loops and extends away from the axon (Peters et al., 
2000), thought to be a marker or remyelination or remodeling of the myelin 
sheath (Rosenbluth, 1966; Sturrock, 1976). Finally, there is a selective increase 
in the number of oligodendrocytes in the cortex (Peters and Sethares, 2004; 
Peters et al., 2008) and an increase in the activation of both astrocytes (Morgan 
et al., 1999; Sloane et al., 2000; Cargill et al., 2012) and microglial cells (Morgan 
et al., 1999; Sloane et al., 1999; Kullberg et al., 2001 ). 
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However, the damage and remyelination present in the aging white matter 
does not account for the loss of white matter staining, as there is also significant 
loss of myelinated axons with age. Studies have shown that there is a reduction 
of 10% per decade from 20 to 80 years old in myelinated nerve fiber length with 
age in human autopsy samples (Marner et al., 2003). In the rhesus monkey, 
there are decreased numbers of myelinated axons in the anterior commissure 
and optic nerve (Sandell and Peters, 2001; 2003). The packing density of 
myelinated axons is decreased in the corpus callosum and fornix (Peters and 
Sethares, 2002; Peters et al., 201 0) and there are more degenerating axon 
profiles present in both the cingulum bundle and genu of the corpus callosum 
(Bowley et al., 201 0). 
At the macroscopic level, MRI studies have disagreed as to whether there 
is white matter loss with age in both humans (Pfefferbaum et al., 1994; Blatter et 
al., 1995; Guttmann et al., 1998; Raz et al., 2005) and rhesus monkeys 
(Andersen et al., 1999; Wisco et al., 2008). The white matter does not appear to 
be universally affected by age with the anterior regions of the brain affected to a 
greater extent than posterior regions (Raz et al., 2005; Salat et al., 2005; Grieve 
et al., 2007; Kennedy and Raz, 2009) and this finding could help explain the lack 
of change in some of the studies using global volume measurements. Also, 
there are changes in MRI signal parameters such as white matter hyperintensity 
and relaxation time, that are markers of tissue integrity (Davatzikos and Resnick, 
2002; Bartzokis, 2004). In addition, diffusion tensor imaging (DTI) MRI 
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sequences have shown that there is a decrease of fractional anisotropy (FA) in 
DTI, which is often considered a marker of myelin breakdown, in both humans 
(Head et al., 2004; Salat et al., 2005; Sullivan et al., 2006; Grieve et al., 2007; 
Kennedy and Raz, 2009) and monkeys (Makris et al., 2007). 
The relevance of these age related alterations in the white matter is shown 
by numerous studies that link the white matter damage to cognitive decline. 
Cognitive decline correlates with measures of white matter damage by both 
electron microscopy (Peters et al., 2000; Peters and Sethares, 2002; Sandell and 
Peters, 2003; Bowley et al., 201 0; Peters et al., 201 0) and MRI (Makris et al., 
2007; Kennedy and Raz, 2009). While the potential contribution of these white 
matter changes to cognitive decline is clear, the cause of the damage is not 
known. 
Molecular Changes in Normal Aging 
Understanding of the basis for the anatomical and physiological changes 
in both the cortex and subcortical white matter has focused on molecular and 
biochemical changes in the aging brain. Microarray studies in many organisms 
indicate that there are changes in expression of a relatively small subset of 
genes with age (1-2%), indicating specific pathways are most likely affected 
instead of just global dysregulation (Lee et al., 2000; Yankner et al., 2008). In 
addition, neuronal gene regulation is affected by age to a greater extent than glial 
gene expression even though these changes do not cause cell death (Loerch et 
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al., 2008). Therefore, studies investigating gene changes with normal aging 
underlying the pathology in white matter need to consider neuronal gene 
expression and the interaction of the neurons and glial cells. 
In the rhesus monkey, many gene array studies have utilized the human 
microarrays available on the market (Kayo et al., 2001; Duce et al., 2008; Lu et 
al., 2008). Some of the molecular changes that have been observed in normal 
aging white matter include a loss of the longevity gene klotho in the subcortical 
white matter (Duce et al., 2008). This promoter region of klotho undergoes 
epigenetic modification, specifically increased methylation with age, helping to 
understand the age related decrease in messenger RNA (mRNA) expression 
(King et al., 2012). In the grey matter, genes related to neurotransmission are 
altered with age with changes in many neutransmitter subunits with age including 
the gamma-aminobutyric acid (GABA) A receptor (Lu et al., 2004; Yu et al., 
2006). In addition, expression of genes related to mitochondrial function are 
susceptible to · age related changes most likely due to inflammatory processes 
and oxidative stress (Lee et al., 1999; Kayo et al., 2001; Prolla, 2002; Blalock et 
al., 2003; Loerch et al., 2008; Peysselon and Ricard-Bium, 2011 ). With the 
sequencing of the rhesus monkey genome now completed (Gibbs et al., 2007), it 
is now possible to run gene expression studies with rhesus monkey specific 
sequences (Ahnet al., 2008; Loerch et al., 2008; Noriega et al., 201 0). 
Alterations of gene expression are often linked to similar alterations in 
protein levels indicating the alteration in gene expression is a functional change 
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in the brain (Duce et al., 2008; Loerch et al., 2008; Cargill et al., 2012). In 
addition to alteration in protein expression levels caused by altered mRNA 
transcript levels, there are also alterations in protein processing and post-
translational modifications with age. There is an age dependent accumulation of 
the myelin associated enzyme 2',3'-cyclic nucleotide phosphodiesterase (CNP) 
that is not associated with alteration in gene expression (Hinman et al., 2008). 
With age, the accumulated CNP is ubiquitinated (Hinman et al., 2008), which is in 
agreement with studies showing the increase of ubiquitin mRNA and protein in 
white matter with age (Dickson et al., 1992; Prolla, 2002; Gray et al., 2003). In 
addition to accumulation, there is also cleavage of the protein with age that is not 
present in the young rhesus monkey (Hinman et al., 2008), which parallels the 
activation of the protease calpain-1 (Hinman et al., 2004). 
One protein whose decreased expression has been implicated in age 
related cognitive decline is brain-derived neurotrophic factor (BDNF) (Croll et al., 
1998). Cognitive performance in non-demented humans has been shown to 
correlate with BDNF levels in the blood and cerebrospinal fluid (CSF) 
(Komulainen et al., 2008; Li et al., 2009). There is a single nucleotide 
polymorphism (SNP) in the prodomain of human BDNF, a valine (Val) to 
methionine (Met) substitution at amino acid 66 (Vai66Met), which has an effect 
on the function of the protein. The Met allele is associated with impaired 
dendritic and axonal transport of the protein and mRNA (Chen et al., 2004; 
Chiaruttini et al., 2009), as well as decreased synaptic release and impairments 
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in learning and memory (Egan et al., 2003; Hariri et al., 2003; Schofield et al., 
2009). The genotype also alters various gross anatomical features in the brain 
including decreased cortical grey matter volumes (Toro et al., 2009), 
hippocampal volume and activation (Hariri et al., 2003; Pezawas et al., 2004), 
and white matter integrity as evidenced by changes in FA by DTI (Kennedy et al., 
2009) and these changes are related to cognitive performance. While SNPs 
generally do not transfer between species, there are instances where there are 
polymorphisms that have similar effects in both humans and rhesus monkeys 
(Miller et al., 2004; Barr et al., 2008). There has been a polymorphism 
discovered in the prodomain of BDNF, a Val to Met transition at codon 46, which 
affects plasma protein levels in infant rhesus monkeys. While it is unknown if this 
SNP has the same functional consequences as the human SNP, it would be 
interesting to determine if this polymorphism is related to cognitive function in the 
rhesus monkey. 
Brain Derived Neurotrophic Factor 
There are four neurotrophic factors in the mammalian brain BDNF, nerve 
growth factor (NGF) neurotrophin 3 (NT-3) and neurotrophin 4 (NT-4). The 
neurotrophins are essential for the growth, differentiation and survival of neurons 
in the brain (Lu et al., 2005) and can bind to two receptors, a preferential receptor 
to which they can bind at high affinity, a tyrosine kinase receptor (Trk), and the 
nerve growth factor receptor (p75). The p75 receptor is able to bind to all of the 
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neutrophins in both their mature and pro forms while the different Trk receptors 
are selectively activated by specific mature neurotophins: NGF binding to TrkA, 
BDNF and NT-4 binding to TrkB, and NT-3 binding to TrkC (Lu et al., 2005; 
Pezet and McMahon, 2006). In order to exert their function on cells, the 
neurotrophins dimerize and bind to the Trk receptors, which subsequently 
dimerizes to initiate intracellular signaling cascades including mitogen activated 
protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K) and phospholipase 
C gamma (PLCy) through trans-autophosphorylation to promote cell survival 
(Meakin and Shooter, 1992; Conner et al., 1997; McAllister et al., 1999; Binder, 
2007; Cowansage et al., 201 0; Yoshii and Constantine-Paton, 201 0). The p75 
neurotrophin receptor can be cleaved by a disintegrin and metalloproteinase 
domain 17 (ADAM17) to release the extracellular domain (ECD) as a free 
receptor and leaving the C-teminal fragment anchored in the membrane (Zupan 
et al., 1989; Barker et al., 1991; Roux and Barker, 2002; Nykjaer and Willnow, 
2012). The c-terminal fragment can be further cleaved by y-secretase to release 
the intracellular domain (lCD) from the transmembrane domain (TMD). The p75 
receptor can activate apoptosis therough the activation of caspases by c-Jun N-
terminal kinase (JNK) 3 (Roux and Barker, 2002; Nykjaer and Willnow, 2012). In 
addition, the lCD can interact with the neurotrophin receptor interacting factor 
(NRIF) causing the ubiquination of NRIF by tumor necrosis factor receptor 
associated factor (TRAF) 6 which allows the complex to translocate to the 
nucleus and cause apoptosis (Skeldal et al., 2011; Nykjaer and Willnow, 2012). 
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The p75 receptor can interacts with other receptors to form complexes, which 
alters the signaling of the receptor. The p75 receptor is able to interact with the 
Trk receptors and signal through the Trk cell suNival pathways through PI3K, 
with the lCD of p75 enhancing the bindinf of NGF to the TrkA receptor (Jung et 
al., 2003; Matusica et al., 2013). 
BDNF is the most studied of the neurotrophins and has other functions in 
addition to growth and differentiation of neurons such as synaptic plasticity where 
it is required for hippocampal L TP (Korte et al., 1995; Patterson et al., 1996; Poo, 
2001; Yoshii and Constantine-Paton, 2010) and is required for the maintenance 
and growth of the dendritic tree (Gorski et al., 2003; Sun et al., 2012). Alterations 
in BDNF mRNA and protein levels have been implicated in a number of 
neurodegenerative diseases including: Parkinson's disease (Mogi et al., 1999; 
Howells et al., 2000), Huntington's disease (Ferrer et al., 2000; Ciammola et al., 
2007), depression (Alexopoulos et al., 201 0; Cirulli et al., 2011) and Alzheimer's 
disease (Phillips et al., 1991; Connor et al., 1997). In Alzheimer's disease, the 
alterations in BDNF levels have been found globally in CSF and plasma (Laske 
et al., 2007; Tapia-Arancibia et al., 2008), in the hippocampus and temporal 
cortex (Phillips et al., 1991; Hayashi et al., 2001; Silhol et al., 2005; 2008) and in 
the inferior parietal lobule (Holsinger et al., 2000; Fahnestock et al., 2002; 
Michalski and Fahnestock, 2003; Peng et al., 2005). While the expression of 
BDNF has been well studied in the neurodegenerative diorders, little is known 
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about the level of BDNF expression with age when neuron number is preserved, 
as is the case of normal aging. 
The BDNF gene is complex, containing between 8 and 11 exons, with 
transcripts formed by alternative splicing of a 5' exon to a common 3' exon 
containing the protein coding sequence and a 3' untranslated region (UTR) to 
form tissue specific transcripts (Metsis et al., 1993; Tim musk et al., 1993; Aid et 
al., 2007; Pruunsild et al., 2007; Greenberg et al., 2009). While the promoter 
region of the gene and 5' exon varies in a tissue and activity dependent manner 
(Liu et al., 2006; Aid et al., 2007; Pruunsild et al., 2007; Baj and Tongiorgi, 2009), 
the 3'UTR can also vary by use of alternative polyadenylation sites (An et al., 
2008). The long 3'UTR allows for transport of the mRNA to the dendrites for 
local translation of the protein, while mRNA containing the short 3'UTR is 
retained in the soma (An et al., 2008). In addition to the 3'UTR translocation 
signal which leads to transport into the dendrites in an activity dependent 
manner, the coding sequence of BDNF contains a dendritic targeting signal that 
is mediated by the single stranded DNA/RNA binding protein translin also known 
as testis brain-RNA binding protein (TB-RBP), and this translocation signal is 
blocked by the Vai66Met SNP in BDNF (Chiaruttini et al., 2009). 
While there are different variations of the BDNF mRNA, all contain the 
identical protein coding sequence. The BDNF protein is synthesized as a 
propeptide (proBDNF) and then cleaved to form the mature protein (mBDNF). 
The proBDNF is processed through the endoplasmic reticulum and Golgi 
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apparatus where it is sorted into secretory vesicles (Greenberg et al., 2009). 
During processing, proBDNF can be cleaved by the endopeptidase turin in the 
Golgi or in the secretory vesicles (Mowla et al., 1999). While it remains 
controversial in the field whether all of the BDNF is cleaved intracellularly or if it 
can be released as proBDNF and exert a biological function (Matsumoto et al., 
2008; Yang et al., 2009), the extracellular serine protease plasmin and matrix 
metalloproteinases (MMP) are able to cleave proBDNF into mBDNF (Lee et al. , 
2001; Pang and Lu, 2004; Nagappan and Lu, 2005; Barker, 2009). 
Environmental cues also regulate the proteolysis of proBDNF, with plasmin 
dependent cleavage important in learning new memories, while cleavage is 
blocked during recall and attenuates learning and promotes extinction of existing 
memories (Barnes and Thomas, 2008). The signaling potential of proBDNF has 
also been demonstrated by the preferential binding to the p75 receptor. The 
interaction of proBDNF and p75 has been shown to mediate long term 
depression (LTD) in hippocampal neurons (Woo et al., 2005), while the binding of 
mBDNF to TrkB mediated long term potentiation (L TP) (Figurov et al., 1996; 
Pang and Lu, 2004 ). With the contrasting functions of the receptors, the role of 
proBDNF in the central nervous system is important and should not be 
overlooked. 
Sorting of BDNF into the secretory granules for regulated release is 
dependent on interactions between the pro-domain and sortilin and this sorting is 
impaired by the Vai66Met polymorphism (Chen et al., 2005) leading to the 
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decreased release seen in hippocampal neurons (Egan et al., 2003; Chen et al., 
2004). In addition to mediating regulated cellular release of BDNF, intracellular 
levels of BDNF are regulated by sortilin dependent lysosomal degradation 
(Evans et al., 2011 ). Cleavage of sortilin by the alpha secretase a disintegrin and 
metalloproteinase domain 10 (ADAM10) protects proBDNF being trafficked to the 
lysosome and allowed for the release of the protein from the cell (Evans et al., 
2011 ). Sortilin promotes proper folding of the mature domain and cleavage of 
proBDNF to mBDNF by turin in a dose dependent manner (Lu et al., 2005; Yang 
et al., 2011) and the level of sortilin is increased in the brains of aged rats (AI-
Shawi et al., 2008; Terry et al., 2011 ). Loss of sortilin binding causes a loss of 
regulated secretion with an increases constitutive release (Chen et al., 2005). 
The sorting of proBDNF into the regulatory secretion vesicles causes transport to 
presynaptic terminals for activity dependent release and this transport is 
dependent on Huntington-associated protein 1 (HAP1) and its interaction with 
sortilin (Wu et al., 2010; Yang et al., 2011 ). Following release and binding of 
BDNF to its receptor, the complex is internalized postsynaptically and undergoes 
retrograde transport back to the soma as a target derived signal (Mufson et al., 
1999) and can also bind on the presynaptic side as an autocrine signal (Poo, 
2001 ). 
In addition to its role in the sorting, processing and degradation of 
proBDNF in the intracellular compartment of the cell, sortilin is also a co-receptor 
with p75 for proBDNF on the cell surface (Teng et al., 2005). Sortilin is a 
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necessary component in the receptor complex with the p75 neurotrophin receptor 
for the induction of apoptosis by the binding of the uncleaved proneurotophins, 
proNGF and proBDNF (Nykjaer et al., 2004; Barker, 2009; Nykjaer and Willnow, 
2012). Sortilin is also involved in the sorting and transport of the Trk receptors to 
the cell surface and can regulate cell survival and cell death due to the balance 
of the signal (Nykjaer and Willnow, 2012). In addition to sortillin, the p75 receptor 
can also interact with several other co-receptors that mediate different cellular 
functions. Association of proBDNF and p75 is able to stop growth cone 
formation through the activation of RhoA (Sun et al., 2012). Neurite outgrowth is 
also stopped and myelination inhibited through the interaction of myelin 
components such as Nogo-66, myelin-associated glycoprotein (MAG), and 
oligodendrocyte myelin glycoprotein (OMgp) with the receptor complex of p75, 
the Nogo receptor (NgR1 ), and LING0-1 (Leucine rich repeat and lg domain 
containing Nogo Receptor interacting protein) (Wang et al., 2002; Wong et al., 
2002; Mi et al., 2004; 2005). This inhibition of axonal growth and inhibition of 
myelination through the p75 receptor is important to the study of normal aging 
with abnormal remyelination and axonal loss. 
Rhesus Monkey Model 
In order to assess the molecular changes that are underlying the white 
matter dysfunction and cognitive deficits observed in normal aging, this thesis 
utilizes the rhesus monkey (Macaca mulatta) model of normal aging. The rhesus 
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monkey model of normal aging has a number of advantages over performing 
similar studies with human brain tissue. First, the lifespan of the rhesus monkey 
is shorter than the human with few animals surviving past 30 years old, with an 
approximate estimation based on lifespan population studies of an age ratio of 1 
year equaling 3 human years (Tigges et al., 1988). Secondly, the confounding 
variables of Alzheimer's disease (AD) neuropathology are removed by using the 
rhesus monkey. Although monkeys exhibit amyloid deposition with age as in 
humans, the predominant form of amyloid beta (A~) that is produced is the 40 
amino-acid isoform and not the longer 42 amino-acid isoform that predominates 
in AD plaques (Gearing et al., 1996). In addition, the formation of amyloid 
plaques does not occur until late in the lifespan of the rhesus monkey, not 
appearing until after 25 years of age, and the plaque burden in the brain is not 
correlated to cognitive function (Sloane et al., 1997). Third, as in humans, the 
rhesus monkey exhibits age-related cognitive declines in working memory (Moss 
et al., 1997a), recognition memory (Moss et al., 1988; Rapp and Amaral, 1989), 
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and executive function (Moore et al. , 2003; 2006). The cognition can be 
assessed using a battery of behavioral tasks similar to the neurocognitive battery 
given to humans for the assessment of cognitive function (Moore et al., 2005). 
Finally, the health of the animals is known from birth, they can be screened for 
diseases that could affect normal brain function and their diet can be regulated in 
ways that would not be possible in human studies. 
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Brain Tissue Harvest and Preservation 
The use of the rhesus monkey also has the advantage of optimal 
preservation of tissue for a variety of different types of experiments. In this 
thesis, all of the subjects used underwent transcardial perfusion at death, which 
eliminates the need to include the post mortem interval in the analysis of human 
tissue. For the molecular studies, samples of the brain were removed during 
perfusion of the brain with cold (4°C) Krebs-Heinseleit buffer (Krebs) and flash 
frozen on dry ice within 15 minutes from the initiation of anoxia and then stored at 
-BOOC until processing. The harvesting during Krebs perfusion allows for the 
flushing of blood from the brain, while still preserving the RNA and proteins in an 
unfixed state for analysis. Following the removal of unfixed tissue samples, the 
perfusate was changed to a warm (3rC) solution of 4% paraformaldehyde in 
phosphate buffer (0.1 M, pH 7.4) to fix the remaining tissue for 
immunohistochemical analysis. 
After perfusion, the right hemisphere of the brain was cut into blocks, 
separating the occipital lobe from the frontal, temporal and parietal lobes (frontal-
main tissue block), and then the tissue blocks were immersed in a cryoprotectant 
solutions of 10% glycerol (2% DMSO, 0.1 M phosphate buffer) overnight, 
changed into a new 10% glycerol solution for 24 hours followed by 5 days in a 
20% glycerol solution (2% DMSO, 0.1 M phosphate buffer) to reduce freezing 
artifacts (Rosene et al., 1986). The blocks were then rapidly frozen by immersion 
in a container of 2-methylbutane cooled to -75°C in a bath of dry ice and 100% 
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ethanol. The frontal-main block of the brain was then stored at -80°C until it is 
ready to be sectioned. For immunohistochemical analysis, the brain was 
sectioned coronally at 301-Jm into 10 interrupted series on a sliding microtome, 
where each section in a series is spaced 3001-Jm apart. The sections were stored 
in vials containing 15% glycerol in phosphate buffer (0.1M, pH 7.4), and frozen at 
-80°C until sections from all animals could be run together in a single batch. 
Inferior Parietal Lobule 
The inferior parietal lobule (IPL) was chosen as the main region of interest 
for this thesis for a number of reasons. First, samples of fresh frozen and fixed 
tissue are available from the IPL of a large cohort of young and aged monkeys 
that have been behaviorally tested to allow for the completion of molecular 
studies. Second, while classically viewed as only multimodal association cortex 
bringing together visual and spatial information, more recent evidence has shown 
that neurons directly fire for specific motor functions, especially the grasping of 
the hand (Pause et al. , 1989; Fogassi et al., 2005; Culham and Valyear, 2006). 
The region is also involved in cognitive functions, specifically spatial working 
memory (Friedman and Goldman-Rakic, 1994; Carpenter et al., 2000; Olson and 
Berryhill, 2009; Berryhill et al., 2010) a domain in which aging monkeys are 
significantly impaired (Walker et al., 1988; Rapp and Amaral, 1989; Voytko, 
1993; O'Donnell et al., 1999). 
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The IPL also has many different connections to areas of the brain that 
would make it important in the cognitive circuit, with connections to the 
hippocampus through both direct connections to CA 1 (Rockland and Van 
Hoesen, 1999; Clower et al., 2001) and disynaptic connections through the 
parahippocampal area TF (Andersen et al., 1990; Blatt and Rosene, 1998; Ding 
et al., 2000), presubiculum and entorhinal cortex (Van Hoesen and Pandya, 
1975; Ding et al., 2000), and the dorsolateral prefrontal cortex (Petrides and 
Pandya, 1984; Cavada and Goldman-Rakic, 1989; Andersen et al., 1990; Jung 
and Haier, 2007; Vincent et al., 2008) and cingulate cortex (Pandya and Seltzer, 
1982). During tasks involving spatial working memory such as spatial delayed 
response, the IPL has been shown to be activated at the same time as the 
prefrontal cortex in both monkeys and humans (Friedman and Goldman-Rakic, 
1994; Bremmer et al., 2001; Broome et al., 2009; Berryhill et al., 201 0). However 
this co-activation is most likely due to the visuospatial and motor components of 
the task and not the cognitive aspect since lesions of the parietal lobe do not 
affect performance on another test of executive function, the Wisconsin Card 
Sorting Task, in the same way as dorsolateral prefrontal cortical lesions (Milner, 
1963). 
Changes in the IPL have been found with age including loss of FA in the 
subcortical white matter (Grieve et al., 2007; Kennedy and Raz, 2009). In 
addition, the IPL is one of the brain regions that is affected relatively early in 
Alzheimer's disease (AD). There are decreases in both grey matter volume 
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(Desikan et al., 2009; Pa et al., 2009) and cerebral blood perfusion (Keilp et al., 
1996) in AD. In addition, changes in this region in grey matter volume and 
cortical thickness are a , good predictors of conversion from mild cognitive 
impairment (MCI) to AD (Desikan et al. , 2009; Greene et al., 2010; Jacobs et al., 
2012). Therefore, gaining a better understanding of the changes occurring in this 
region during normal aging is important to gaining information about the 
differences between normal and pathological aging. 
Approach to the Dissertation 
The overall goal of this dissertation is to investigate whether changes in 
molecules related to axonal survival and myelination are altered in the aging 
rhesus monkey brain. 
In Chapter II, age-related molecular changes in the IPL were determined 
in fresh-frozen unfixed tissue samples. The study aims to determine possible 
changes in a number of genes to determine which genes have altered 
expression profiles in the cortical grey matter and subcortical white matter of the 
IPL. Utilizing real-time PCR, the expression levels of four genes that were 
identified from a larger screen was examined in 27 rhesus monkeys ranging in 
age from 4.2-30.4 years old . The level of protein expression of these genes was 
also measured in order to determine if the alteration seen at the mRNA level is 
representative of a change in protein expression. 
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In chapter Ill, age-related changes in proBDNF expression were assessed 
by immunohistochemistry in the IPL and hippocampus in paraformaldehyde fixed 
tissue in a separate cohort of 36 subjects ranging in age from 7.4 to 27.8, with 
only 4 subjects overlapping from the molecular studies. The goal of this study 
was both to attempt to localize the change in proBDNF expression in the IPL 
grey matter, which was found by western blot, and to determine if the level of 
expression is similarly changed with age in subregions of the hippocampus, 
which did not have fresh-frozen tissue available for western blot analysis. While 
the western blot data of proBDNF expression in Chapter II give an overall level of 
expression of the protein in the IPL, it is unable to determine where the protein is 
expressed in the cortex. The immunohistochemical data allows for the 
examination of both the expression contained within the soma and extrasomal 
expression of the protein as well as what cell types are expressing the protein. 
Also, the immunohistochemistry on the entire frontal-main block from one 
hemisphere allows for the analysis of protein levels in regions of the brain where 
fresh-frozen unfixed tissue samples are not readily available. 
In Chapter IV, the overall findings of this study are discussed, including 
the potential relationship to the myelin dysfunction, axonal loss and cognitive 
decline that is observed during aging. In addition, areas for further investigation 
are presented. 
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CHAPTER II 
Molecular Changes in the Inferior Parietal Lobule Cortical Grey Matter and 
Subcortical White Matter with Age 
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Introduction: 
Studies of neurodegenerative diseases such as Alzheimer's have revealed 
widespread loss of neurons in the cortex and other areas of the human brain 
including the nucleus basalis of Meynert and locus coeruleus (Tomlinson et al., 
1981; Arendt et al., 1983; West et al., 1994; G6mez-lsla et al., 1996; Gomez-lsla 
et al., 1997; Zarow et al., 2003). In contrast, in normal aging humans who 
escape frank neurodegenerative diseases, growing evidence indicates that 
neurons are preserved even though there is mild cognitive decline (Terry et al., 
1987; G6mez-lsla et al., 1996; Peters et al., 1998; Freeman et al., 2008). In 
searching for the neurological bases of these cognitive impairments, age-related 
pathology in white matter has been reported in humans (Lintl and Braak, 1983; 
Kemper, 1994; Bartzokis et al., 2003; 2004; Kennedy and Raz, 2009) and in the 
rhesus monkey model for normal aging (Peters et al., 1997a; 2000; Hinman and 
Abraham, 2007; Makris et al., 2007; Wisco et al., 2008). The monkey studies 
have been particularly illuminating as the monkey has brain structure and 
cognitive functions more similar to humans than other laboratory species, is long-
lived with maximal life spans over 30 years of age, and allows optimal 
preparation of brain tissue in close proximity to behavioral assessments. Using 
behaviorally characterized rhesus monkeys, studies have shown that white 
matter changes are strongly associated with age-related cognitive impairments 
(Peters et al., 2000; Makris et al., 2007; 201 0). Moreover, both electron 
microscopic (Bowley et al., 2010; Peters and Kemper, 2012) and biochemical 
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studies (Hinman and Abraham, 2007; Duce et al., 2008) have shown that the 
white matter changes are associated with a variety of pathological changes in 
myelin. Some of these changes in white matter include, a decrease with age of 
both the messenger ribonucleic acid (mRNA) and protein levels of klotho as well 
as an increase in the level of the methylation in the proximal promoter region 
(King et al., 2012). In addition, there is an increase in both the level of 
expression and fragmentation of the oligodendrocyte enzyme, CNP (Sloane et 
al., 2003; Hinman et al., 2008) as well as an increase in the white matter of 
activation of astrocytes and microglia (Sloane et al., 1999; 2000). Nevertheless, 
the causes of the myelin pathology are not understood. Possible mechanisms 
include damage to myelin by age-related oxidative stress and/or inflammation, 
age-related loss of oligodendroglia! capacity for myelin maintenance and repair 
(Chen et al., 2013), or age-related declines in molecular signaling pathways 
essential for myelin homeostasis (Nave and Trapp, 2008; Nave, 201 0). In order 
to explore this latter possibility, the present study used a custom PCR gene array 
approach to explore a number of candidate molecular pathways critical to 
homeostasis and followed-up several of the more promising leads. The pathways 
examined included neurotrophic factor signaling, GABAergic neurotransmission 
and inflammatory cytokines. Of these, the most interesting positive finding was 
in gene expression levels of brain derived neurotrophic factor (BDNF). 
Alterations in BDNF mRNA and protein levels have been implicated in a number 
of neurodegenerative diseases including: Parkinson's disease (Magi et al., 1999; 
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Howells et al., 2000), Alzheimer's disease (Phillips et al., 1991; Holsinger et al., 
2000), and Huntington's disease (Ferrer et al., 2000; Ciammola et al., 2007). 
Human studies have also pointed towards the importance of BDNF in normal 
cognitive aging, with decreased CSF levels correlating with cognitive decline (Li 
et al., 2009), and decreased plasma levels relate to age related white matter loss 
(Driscoll et al., 2012). The present study reports a decrease in the level of BDNF 
mRNA and the precursor protein, proBDNF, in the cortex of the inferior parietal 
lobule, one of the brain regions affected early in the development of mild 
cognitive impairment and Alzheimer's disease (Greene et al., 2010; Jacobs et al., 
2012). These findings are important to understanding the role of BDNF 
expression throughout the complete adult life span in the absence of 
neurodegeneration. 
Methods: 
Subjects: A total of twenty-seven adult monkeys (Macaca mulatta), 14 male and 
13 female, ranging in age from 4.4 to 30.4 years were used in this study as 
summarized in Table 1. · Monkeys were obtained from colonies of the Yerkes 
National Primate Research Center (Atlanta, GA) and Labs of Virginia 
(Yemassee, SC). Before entering the study, they were screened for any diseases 
that could affect the central nervous system as well as given MRI scans to 
screen for occult brain damage. Animals were housed in the Laboratory Animal 
Science Center of Boston University Medical Campus (BUMC), which is fully 
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accredited by the Association for the Assessment and Accreditation of 
Laboratory Animal Care. All procedures and care of the animals was under the 
strict guidance of the National Institutes of Health guidelines and the Guide for 
the care and use of laboratory animals (1996) and approved by the Institutional 
Animal Care and Use Committee of BUMC. 
Cognitive Assessment: The majority of monkeys received a battery of 
behavioral tasks to assess cognitive performance. These tasks have been 
described in detail elsewhere (Herndon et al., 1997; Moore et al., 2005) but 
briefly included measures of learning (acquisition of the Delayed Non-Match to 
Sample Task - DNMS), recognition memory (delay conditions on DNMS), 
working memory (object and spati~l conditions of the Delayed Recognition Span 
Task- DRST}, attention, associative memory and executive function (learning the 
stimulus categories and shifting set in Category Set Shifting Task- CSST). 
Tissue Harvest: At the conclusion of all testing, subjects were deeply 
anesthetized to a surgical level with sodium pentobarbital, their head fixed in a 
stereotactic device and a partial craniotomy done. The chest was then opened 
and they were transcardially perfused with 4 to 8 liters of ice-cold (4°C) Krebs-
Heinseleit buffer (6.41 mM Na2HP04, 1.67 mM NaH2C03, 137 mM NaCI, 2.68 
mM KCI, 5.55 mM Glucose, 0.34 mM CaCb, 2.14 mM MgCI2, pH 7.4) prepared in 
RNase free conditions. After all blood was cleared but while the buffer was still 
flowing, fresh samples of cortex and underlying white matter were removed from 
the dorsal half of the left inferior parietal lobule (IPL), flash frozen on dry ice and 
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stored at -80°C until processed for molecular and biochemical studies. All 
samples were frozen within 15 minutes from the start of anoxia. Samples from 
the IPL were dissected into the cortical grey matter and subcortical white matter 
either prior to freezing or while frozen as indicated in Table 1. Once the fresh 
samples were removed the perfusion was switched to 4% paraformaldehyde in 
0.1 M phosphate buffer (pH 7.4, 3rC) to fix the remainder of the sampled 
hemisphere and the entire intact hemisphere so that they could be cryoprotected 
and frozen for additional studies. 
RNA and Protein Extraction: Tissue blocks from the IPL were dissected into 
cortical grey matter and subcortical white matter pieces weighing 1 OOmg to 
isolate the RNA and protein using TRizol solution following the manufacturer's 
protocol (Invitrogen). Briefly, 1 OOmg of tissue was added to 1 ml of TRizol reagent 
and homogenized with a handheld pestle and passed through a 20-gauge 
needle. The RNA extract was further processed using RNeasy Mini Kit and 
treated with DNase I (Qiagen) to clean up the RNA and remove any DNA 
contamination. The integrity and the concentration of the RNA were determined 
by UV Spectrophotometry using a NanoDrop1 000 (Thermo Scientific). The 
protein was then isolated from the phenol-ethanol supernatant and washed with 
0.3M guanidine hydrochloride in 95% ethanol and dissolved in 1 %SDS. The 
concentration of the protein was determined using the BCA Protein Assay 
(Pierce Biotechnology). Extracts of RNA and protein were then stored at -8ooc 
until analyzed. 
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PCR Array: A subset of the total number of subjects, seven old and five young 
female monkeys (identified in Table 1 ), was processed to identify potential gene 
targets utilizing custom PCR gene array plates containing primers sets for 90 
genes of interest and 3 reference genes for normalization and 3 PCR quality 
controls. These PCR arrays were designed and obtained from SABiosciences 
(Frederick, MD) using the rhesus monkey gene sequences. Briefly, 0.5f,tg total 
RNA was used in the reverse transcriptase reaction. Then, 1 Ofll of reaction 
containing the eDNA template and detection reagents were loaded into each well 
of the plate and the PCR was run as follows: 1 cycle of 95°C for 10 minutes 
followed by 40 cycles of (95oC for 15s and 60°C for 1 min) using SYBR green 
detection on an Applied Biosystems (ABI) Prism 7900HT sequence detection 
system. The relative fold changes in gene expression were analyzed by 
comparing the group means of the young versus old animals using comparative 
CT method (Z~cT) and normalizing values to the average of the three 
housekeeping genes included in the array: beta-actin (ACTB), glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), and cyclophillin A (PPIA). 
Quantitative Real Time PCR (qPCR}: To confirm the PCR array results, real 
time PCR was run on 27 male and female monkeys (Table 1) using TaqMan 
primer and probe sets designed to rhesus monkey genes were purchased from 
Applied Biosystems (brain-derived neurotrophic factor (BDNF): Rh02788328_s1; 
meltrin-beta (ADAM19): Rh02851168_m1, neurotrophic tyrosine kinase, 
receptor, type 2 (NTRK2): Rh02831791_m1, nerve growth factor receptor 
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(NGFR): Rh02842493_m1; leukemia inhibitory factor-like (LOC715456): 
Rh02841805_m1). Control primers and probes to 188 rRNA (Applied 
Biosystems, 4308329) or RPL 13A (sequences from(Noriega et al., 201 0)) were 
used in a multiplex assay. Total RNA was tested for expression using 40 ng total 
RNA from the grey matter, and 60 ng RNA from the subcortical white matter for 
BDNF, ADAM19, and NTRK2. For gene expression of NGFR 300 ng of total 
white matter RNA was analyzed. Thermocycling was done on an ABI PRISM 
7900 HT using the parameters of 50°C for 30 minutes, 95°C for 10 min, and 50 
cycles of 95°C for 15 seconds and 60oc for 1 min. A standard curve was run for 
each reaction with the RNA of a young subject that allowed for the determination 
of the quantity of the RNA expression for each gene analyzed, and the data were 
normalized to 18S rRNA expression or RPL 13A expression for NGFR to 
minimize the difference between the threshold cycle (Cr) values between the 
gene of interest and the normalization gene. 
Antibodies: To assess protein levels, western blot analysis was done using 
antibodies against proBDNF (Aiomone Labs, ANT-006 Lot AN-05), BDNF (Santa 
Cruz Biotechnology, sc-546), NTRK2 (Millipore, AB5372), NGFR (Novus 
Biologicals, M-009-1 00), ~-tubulin (Invitrogen, 32-2600), Myelin Oligodendrocyte 
Glycoprotein (MOG) (Millipore, MAB5680) and secondary detection antibodies 
utilized were HRP linked goat anti-mouse and goat anti-rabbit (GE Life 
Sciences). 
Western Blot Analysis: Protein samples were diluted 1:3 with a 3X sample 
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buffer prepared fresh (240 mM Tris-HCI, pH6.8, 6% SDS, 30% Glycerol, 16% f3-
mercaptoethanol) and heated to 95°C for 10 minutes before loading the protein 
into a 4-20% Tris-Giycine gel (Mini Protean TGX, Bio-Rad). For all blots, 20 fAg 
of total protein was loaded on the gel. The gel was run at 200V for 30 minutes in 
running buffer (193 mM Glycine, 25 mM Tris Base, 0.1% SDS). The protein was 
then transferred to a polyvinylidene difluoride (PVDF) membrane at 0.2A for 2 
hours in transfer buffer (39 mM Glycine, 48 mM Tris Base, 20% Methanol). After 
transfer the membranes were rinsed in Tris Buffered Saline containing 0.1% 
Tween-20 (TBST) and then blocked with 5% Non-Fat Dry Milk in TBST for 1 hour 
at room temperature (RT). Membranes were then incubated overnight at 4 oc in 
primary antibody (BDNF 1:200, pro-BDNF 1:500, TRKB 1:1000, NGFR 1 :500). 
Membranes were then washed in TBST and then incubated in HRP linked 
secondary antibody (1 :20,000) in blocking buffer for 2 hours at RT. Then the 
membranes were further washed and the proteins were visualized using 
Amersham ECL Western Blotting Detection Reagents and Amersham Hyperfilm 
ECL (GE Healthcare). 
The membranes were rinsed in TBST and the HRP activity was 
inactivated by rinsing the blot in 100% ethanol and then in 15% hydrogen 
peroxide in TBST for 15 minutes at 37°C (Sennepin et al., 2009), and washed 
again in TBST and blocked for 1 hour at RT in blocking buffer. Finally, for 
normalization, the membranes were probed with antibodies for f3-tubulin (1 :1 000) 
for grey matter samples or MOG (0.31-Jg/ml) for the white matter samples. Protein 
33 
expression was quantified by measuring the density of the bands of the protein of 
interest using lmageJ (NIH) and normalizing to the reference protein . Controls 
utilized were omission of the primary antibody as well as preabsorption of the 
proBDNF antibody with a 80-fold molar excess of the included antigen (Aiomone 
Labs, Lot AG-02) to determine antibody specificity. 
Statistical Analysis: The PCR gene array was analyzed as fold change in 
expression in the old (20.1-28.1 years old) versus the young (4.4-1 0.1 years old) 
animals and t-tests were run for each gene on the array. For array data, the 
Benjamini and Hochberg False Discovery Rate was preformed to correct for the 
problem of multiple comparisons but because of the small sample, it eliminated 
significance from even the largest fold change effects. Hence the uncorrected 
values are presented since we performed Real Time PCR and western blots on 
individual genes to follow up on the array results and eliminate the need for 
multiple comparison correction. The individual gene and western blot results 
were analyzed with Pearson Correlation analysis with statistical significance set 
at p :50.05. 
Results: 
Gene Expression 
PCR Array: The PCR array was custom designed to include genes that 
are related to known anatomical and functional changes that occur in the aging 
brain, such as myelin degeneration and loss of axons as well as alterations in 
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cognitive function. The genes included on the array fell into 7 main categories: 
neurotrophic factors and receptors, transcription factors, GABA 
neurotransmission, inflammatory cytokines, intracellular adaptor and signaling 
molecules, proteases and cellular organization. Of the 90 genes, there were 
significant changes with age in 9 genes in the cortical grey matter and 7 genes in 
the subcortical white matter in the inferior parietal lobe comparing the aged and 
the young female rhesus monkey before correction for multiple comparisons, as 
shown in Table 2. These alterations in expression occurred in genes from each 
of the main functional categories of genes in the array, illustrating the diversity of 
the aging process. While there were no age-related changes that were 
significant following the correction for multiple comparisons, and therefore the 
changes found could represent false positive results, the PCR array was used to 
direct the further investigation of age-related alterations in gene expression. 
While alterations in many of these genes could play important roles in the 
changes of the aging brain, four were selected for further analysis and 
confirmation based on both the fold change as well as their role in neuronal 
function, axonal survival and myelination. First, BDNF was selected because of 
its role as a target derived neurotrophic factor important in neuronal survival 
(Murer et al., 2001) and dendritic (Gorski et al., 2003) and synaptic (Lu, 2003; 
Bamji et al., 2006) maintenance and because it was similarly altered in both the 
cortical grey matter (fold change = -1.82) and the subcortical white matter (fold 
change = -1.78). Secondly, one of the receptors for BDNF and other 
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neurotrophic factors, NGFR, was selected because it was increased in the 
subcortical white matter (fold change = 2.14) and is involved in the signaling of 
myelination in the white matter with BDNF promoting myelination and myelin 
components inhibiting myelination (Cosgaya et al., 2002; Wang et al., 2002; 
Wong et al., 2002; Du et al., 2006). ADAM19 was selected since it was 
decreased in the grey matter (fold change = -1.99) and is important for the 
cleavage of Neuregulin-1 (Shirakabe et al., 2000; Yokozeki et al., 2007), a 
signaling molecule for oligodendrocyte survival and myelin sheath thickness in 
the spinal cord and peripheral nervous system (Michailov et al., 2004; Vartanian 
et al., 1997; 1999). The gene, leukemia inhibitory factor (LIF) was also selected 
for further analysis since it had the highest fold change (fold change = 3.38) of 
any of the potential targets and had been shown to be important in 
oligodendrocyte survival and differentiation (Mayer et al., 1994; Butzkueven et 
al., 2002; Kerr and Patterson, 2005). Finally, the high affinity BDNF receptor, 
NTRK2, while it was not included on the PCR array due to design constraints, 
was selected for analysis to determine if there are alterations in other 
components of BDNF signaling. 
Quantitative Real Time PCR (qPCR): Confirmation of the PCR array 
results was done with TaqMan qPCR in the full cohort of 27 animals shown in 
Table 1. With this expansion, BDNF mRNA was significantly decreased with age 
in the cortical grey matter (r=-0.641, p=0.0003, Figure 1 A), while the decrease 
approached significance in the subcortical white matter (r=-0.313, p=0.11, Figure 
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2A) when standardized to the expression of 188 rRNA. The two main receptors 
for BDNF were then examined to determine how their expression was altered. 
The first, NGFR, was examined based on the results from the array and it was 
significantly increased in the subcortical white matter (r=0.403, p=0.041) when 
standardized to an alternate housekeeping gene RPL 13A (Figure 28) in 26 
subjects as one failed to reach the level of detection. The expression of NGFR 
was too low to be detected in the cortical grey matter with this primer and probe 
combination. RPL 13A was chosen for the normalization of NGFR expression to 
reduce the difference between the threshold cycle for the gene of interest and the 
normalization gene. The utilization of this alternative normalization gene did not 
change the relationship of BDNF with age that was found by normalization to 188 
rRNA in the subcortical white matter (data not shown). In addition, the main 
receptor for BDNF represented by the gene NTRK2, was analyzed to determine 
if the entire BDNF system is altered with age even though this gene was not 
included on the PCR array due to design constraints. In contrast to NGFR, 
NTRK2 was found to be unaltered in both the cortical grey (r=-0.041, p=0.84, 
Figure 1 B) and in the subcortical white matter (r=-0.018, p=0.93, Figure 2C). 
Finally, the mRNA levels of ADAM19 were decreased with age in the cortical 
grey matter (r=-0.519, p=0.0056, Figure 1 C) while not being altered in the 
subcortical white matter (r=-0.203, p=0.31, Figure 20) confirming the array 
results. Because the level of expression of NGFR in the grey matter and LIF in 
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the grey and white matter was below the level of detection in the current 
experiment, the data is not presented and these genes were not pursued further. 
Protein Expression 
The results from the expression of 8DNF mRNA and its two receptors' 
mRNAs constituted the system with the most information and were therefore 
selected for analysis of protein expression to determine if the changes that are 
seen at the mRNA level translate to a functional protein change for either the 
mature form of 8DNF or the precursor, pro8DNF. The mature 8DNF migrates as 
a 14 kDa band on the western blot and was standardized to the expression of 13-
tubulin in the grey matter and MOG in the subcortical white matter. The precursor 
form of 8DNF, pro8DNF, was detected as a 34 kDa band on the western blot. 
While there was no change with age in protein levels of mature 8DNF in the 
cortical grey matter (r=-0.019, p=0.97; Figure 3A) or in the subcortical white 
matter (r=-0.183, p=0.39; Figure 4A), pro8DNF was found to be significantly 
decreased in the cortical grey matter (r=-0.408, p=0.035; Figure 38), but not in 
the subcortical white matter (r=-0.267, p=0.18; Figure 48). The protein 
expression of the 75 kDa band representing the full-length p75 (NGFR) receptor 
was not significantly altered with age in the subcortical white matter (r=0.19, 
p=0.33; Figure 4C). There was also no change in the protein expression with 
age of either the full-length Trk8 receptor identified as a 148 kDa band in the 
grey matter {r=-0.32, p=0.099; Figure 3C) and subcortical white matter {r=-0.27, 
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p=0.18; Figure 40) or the truncated form of TrkB represented by a 95 kOa band 
in the grey matter (r=-0.1 01, p=0.62; Figure 3C) or the subcortical white matter 
(r=-0.049, p=0.82; Figure 40). The level of AOAM19 protein expression was not 
examined in the cortical grey matter or the subcortical white matter due to the 
lack of a specific antibody. 
Discussion: 
The object of this study was to determine if there are changes in the 
expression of genes related to the preservation of the axons and white matter as 
a function of age. Our original gene screen using the PCR array and subsequent 
confirmation differs from previous microarray studies in the rhesus monkey that 
focused on the white matter dysregulation (Ouce et al., 2008) because it utilized 
primers and probes directed towards the rhesus monkey genome rather than the 
human genome. Also, this study analyzed both the cortical grey matter and the 
subcortical white matter to determine if there were changes in the mRNA 
expression in the neurons that could have an effect on the interactions with the 
glial cells when the protein is in the axon reflected by changes in the grey matter 
or the glial cell acting on the axons in the subcortical white matter. 
The PCR array identified several different potential targets where the 
expression of mRNA was altered with age. These changes confirm the 
heterogeneity of the aging process that have been found in microarray studies 
(Blalock et al., 2003; Ouce et al., 2008; Fraser et al., 2005; Loerch et al., 2008; 
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Yankner et al., 2008). With the small sample size used, seven aged and five 
young, the power of the experiment was not great enough to allow any of the 
genes to survive the Benjamini and Hochberg False Discovery Rate correction 
for the 90 genes of interest. However, the findings from the array were used to 
direct the selection of genes to confirm expression in a larger sample size based 
on the relationship of gene function to white matter integrity, neuronal and axonal 
survival. 
Not all of the genes that were identified by the array could be confirmed by 
qPCR. In the cortical grey matter, while BDNF and ADAM19 did not have the 
highest fold changes of any of the identified genes, they were among the most 
significant prior to multiple comparison correction and could be confirmed in the 
expanded sample. On the other hand, the level of significance and fold change 
of BDNF in the subcortical white matter were lower than in the grey matter and 
they could not be confirmed by qPCR. ADAM19, while not significantly altered in 
the subcortical white matter on the array was also analyzed by qPCR in the 
expanded subject set and there was no significant relationship with age 
confirming the PCR array. The increase in the nerve growth factor receptor with 
age in the subcortical white matter was also confirmed by qPCR. The gene with 
the highest fold change on the array, LIF, could not be confirmed by qPCR 
because the expression level in the young animals in the expanded subject list 
fell below the level of detection. So while the primer and probe set did work to 
amplify the gene, the sensitivity of the reaction at the level of starting RNA that 
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could be added to the reaction was not sufficient to allow for the successful 
completion of the experiment. 
The failure to confirm the changes of BDNF in the subcortical white matter 
could be due to several causes. First, the findings may have been false positives 
since the array results were not adjusted for multiple comparisons. Secondly, 
although the two experiments used the same RNA preparations for the repeated 
subjects, the experiments utilized different normalization factors, which could 
alter the relationship with age of the gene of interest. The PCR array was 
normalized to the average expression of three genes (ACTB, GAPDH, PPIA) as 
separate reactions while the qPCR was run as a multiplex reaction with a single 
housekeeping gene of either 18S rRNA or RPL 13A. Finally, another factor that 
may affect the ability to confirm the changes in the expression of the genes is the 
presence of multiple isoforms of the gene from differential splicing and alternate 
transcription start sites. All of the genes that were successfully analyzed by 
qPCR have differentially spliced isoforms of mRNA. The qPCR primer and probe 
sets used for the validation experiment are designed to capture all known 
isoforms of the mRNA and therefore capturing the total transcript expression. 
However, since SABiosciences designed the primers used in the PCR array, the 
location of the primers in the transcript is not known and therefore could be 
designed at a site that would only capture certain isoforms of the mRNA. BDNF 
has multiple different transcripts formed from different transcription start sites and 
alternative splicing of 5' exons with a common 3' protein coding exon (Aid et al., 
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2007; Timmusk et al., 1993; Pruunsild et al., 2007), and the qPCR primers are 
contained in the common 3' protein coding sequence. ADAM19 has two main 
alternatively spliced transcripts (Kurisaki et al., 2002; Ehrnsperger et al., 2005), 
with the qPCR primers spanning the exon 5-6 boundary, where the transcript 
difference is with exon 12 and 13. The qPCR primers for NGFR span the exon 
boundary between exons 1 and 2 and would also examine both the short and 
full-length transcripts (Schack et al., 2001) which differ in the inclusion of exon 3. 
The high affinity BDNF receptor NTRK2 has many different transcripts formed 
from both alternative start sites as well as splice variants, the qPCR primers span 
the exon 11-12 boundary and capture all transcripts that retain the capability of 
binding BDNF in the translated protein (Luberg et al., 2010). Any of these 
differences between the PCR array and qPCR experiments either alone or in 
combination can explain why the level of gene expression could not be confirmed 
for all of the genes. 
While the level of gene expression is important, it is important to 
determine if the level of gene expression is representative of a change in the cell 
at the protein level. The decrease in BDNF mRNA expression in the grey matter 
of the IPL is related to a decrease in the level of proBDNF while there is no 
change with age in the mature form. This finding is similar to those in rat where 
aging had a specific effect on the level of proBDNF without affecting mBDNF 
levels (Perovic et al., 2012). In the subcortical white matter there were no 
significant changes in either proBDNF or mBDNF following the lack of significant 
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alteration at the mRNA level. The other significant gene expression change was 
an increase the nerve growth factor receptor (p75) with age in the subcortical 
white matter, while there was no change in the protein expression of the full-
length receptor. NTRK2 (TrkB) did not have significant relationships with age in 
either the grey matter or the subcortical white matter at the mRNA level or the 
protein level when analyzing both the full-length receptor and the truncated 
receptor lacking the kinase domain. 
One limitation to this study is the lack of representation of subjects in the 
middle age range from 13-19 years of age. Therefore we are unable to 
determine if the trends and changes in mRNA and protein expression are truly 
linear or if there is differential regulation in the middle age range. This is 
important because in the rat, studies have found a transient decrease in the p75 
receptor protein at 12 and 18 months of age with recovery of expression at 24 
months to levels similar to 6 months of age (Perovic et al., 2012). If regulation of 
the p75 protein in the rhesus monkey were similar to the rat, this would not be 
seen in the current sample used in this study. In addition, alterations in NTRK2 
expression in the aging cortex have been shown in humans, but it was a layer 
specific change with a significant decrease in full-length TrkB mRNA in layers II 
and Ill in the prefrontal cortex (Romanczyk et al., 2002), resolution of the 
alteration that is not possible in this current study, 
The most interesting result from this study is the specific decrease of 
proBDNF with age. Levels of both proBDNF and mature BDNF are decreased in 
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the parietal cortex in both mild cognitive impairment and Alzheimer's disease 
(Holsinger et al., 2000; Michalski and Fahnestock, 2003; Peng et al., 2005), 
suggesting a relationship to the progression of the disease state. In contrast to 
the human studies looking at frank neurodegeneration in AD versus age-matched 
controls, the present study examined the full adult age range, including subjects 
from 4-30 years old, which equates to humans from 12 to 90 years of age (a 1:3 
age ratio with humans (Tigges et al., 1988). Also, since the rhesus monkey does 
not develop Alzheimer's disease (Sloane et al., 1997), and does not lose 
forebrain neurons (Peters et al., 1998; Roberts et al., 2012; Giannaris and 
Rosene, 2012) this study shows that there is a decrease in the level of BDNF 
mRNA and proBDNF protein in the absence of neuron death. 
ProBDNF activating the p75 receptor activates apoptosis pathways (Teng 
and Hempstead, 2004; Koshimizu et al., 2009) and inhibits neurite outgrowth 
(Wang et al., 2004; Wong et al., 2002), while mature BDNF binding to the high 
affinity receptor, trkB, promotes survival of the neuron (Lewin and Barde, 1996; 
Huang and Reichardt, 2001; 2003) and synaptic plasticity (Poo, 2001 ). Since 
there is preservation of neuron number with age, sublethal changes in signaling 
and neuronal health have been suggested to account for the changes seen with 
normal aging (Morrison and Hof, 1997). One of these changes is potentially an 
increased cleavage or degradation of proBDNF to preserve the mature BDNF 
levels and shift the balance of signaling between the two forms of the protein in 
order to maintain the neuron. 
44 
While neurons are preserved with normal aging, there are losses of 
dendritic spines and synapses (Dickstein et al. , 2007; Peters et al., 2008; 
Dickstein et al. , 2012) as well as axons (Sandell and Peters, 2001; 2003; Bowley 
et al., 201 0). There are also changes in white matter integrity (Grieve et al. , 
2007; Makris et al., 2007; Kennedy and Raz, 2009) and damage to the myelin 
sheaths (Feldman and Peters, 1998; Peters et al., 2000; 2001; Peters and 
Sethares, 2002). BDNF is a trophic factor that is released at synapses in an 
activity dependent manner as both proBDNF and mBDNF (Matsumoto et al., 
2008; Yang et al., 2009) and signal across the synapse as a retrograde support 
signal of the axon (Mufson et al., 1999), with proBDNF signaling neurite 
retraction and spine loss (Kotlyanskaya et al., 2013; Singh et al. , 2008; Sun et 
al., 2012; Yoshii and Constantine-Paton, 201 0). The differentiation and 
development of oligodendrocytes are also dependent on BDNF and therefore the 
decrease in the signal with age may be related to the alterations in the myelin 
sheath and the loss of axons visible in the aging white matter. While this study 
did not find significant changes in the white matter at the protein level, if the 
increase in mRNA of the p75 neurotrophin receptor would be found in a larger 
sample size or in the examination of the cleavage products of the receptor that 
may explain the dysmyelination. Activation of the p75 receptor by BDNF or NGF 
stimulates myelination (Cosgaya et al. , 2002; Du et al., 2006) but activation by 
myelin components inhibits myelination (Wang et al. , 2002; Wong et al., 2002; Mi 
et al., 2004; 2005). More information is necessary to determine if a change in the 
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ratio of signaling between these pathways could explain the abnormal 
remyelination that is observed with aging (Peters et al., 2000; 2001; Peters and 
Sethares, 2003). 
This study is the first to comprehensively look at the levels of the 
neurotrophic factor BDNF and its receptor throughout the lifespan in the rhesus 
monkey. The findings of this study supplement studies in aging rats and humans 
that show that neurotrophic factor signaling is altered in the aging brain. Further 
understanding of the levels of proBDNF and its processing to mBDNF in other 
cortical and subcortical regions of the brain is necessary to the understanding of 
the potential role of the proBDNF in the pathological changes evident in the aging 
brain. 
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Table 1: Subject Data 
ID Age Sex Perfusate Source Experiments Run GMIWM {years} Dissection 
AM081x 4.2 M Krebs YNPRC qPCR+WB Frozen 
AM147x 4.4 F Krebs YNPRC Array+qPCR+WB Frozen 
AM078 5.7 F Krebs YNPRC Array+qPCR+WB Frozen 
AM146x 6.3 F Krebs YNPRC Array+qPCR+WB Frozen 
AM131 6.6 F Krebs YNPRC Array+qPCR+WB Frozen 
AM148h 7.3 M Krebs YNPRC qPCR+WB Frozen 
AM127 7.3 M Krebs YNPRC qPCR+WB Frozen 
AM145x 8.7 M Krebs LabVA qPCR+WB Frozen 
AM092b 8.8 M Krebs YNPRC qPCR+WB Frozen 
AM163 10.1 F Krebs YNPRC Array+qPCR+WB Frozen 
AM079x 10.8 M Krebs YNPRC qPCR+WB Frozen 
AM139x 12.6 M Krebs Lab VA qPCR+WB Frozen 
AM252 19.9 F Krebs YNPRC qPCR+WB Fresh 
AM160 20.6 F Krebs YNPRC Array+qPCR+WB Frozen 
AM256 20.7 F Krebs YNPRC Array+qPCR+WB Fresh 
AM126 20.9 F Krebs YNPRC Array+qPCR+WB Frozen 
AM123 21 .0 M Krebs YNPRC qPCR+WB Frozen 
AM165 22.6 M Krebs YNPRC qPCR+WB Frozen 
AM067L 24.0 M Krebs YNPRC qPCR+WB Frozen 
AM243 24.4 M Krebs YNPRC qPCR+WB Fresh 
AM164 24.5 M Krebs YNPRC qPCR+WB Frozen 
AM107b 26.0 F Krebs YNPRC Array+qPCR+WB Frozen 
AM120 26.5 F Krebs YNPRC Array+qPCR+WB Frozen 
AM098 28.1 F Krebs YNPRC Array+qPCR+WB Frozen 
AM082 28.1 F Krebs YNPRC Array+qPCR+WB Frozen 
AM048L 30.2 M Krebs YNPRC qPCR+WB Frozen 
AM073 30.4 M Krebs YNPRC qPCR+WB Frozen 
Abbreviations: Krebs, Krebs-Heinseleit buffer; YNPCR, Yerkes National Primate Research 
Center, Atlanta , GA; LabVA, Labs of Virginia, Yemassee, SC. Array, PCR Array; qPCR, 
quantitative real time PCR; WB, western blot 
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Table 2: Genes with Altered Expression in the Inferior Parietal Lobule by qPCR Array 
Accession Fold Gene Symbol Gene Name N b R 1 t" p-value* urn er egu a 1on 
IPL Cortical Grey Matter 
IL 1~ interleukin 1, beta NM 001042756 2.45 0.0492 
GADD45G growth arrest and DNA-damage-inducible, gamma XM_001091127 2.02 0.0188 
MYC v-myc myelocytomatosis viral oncogene homolog XM 001083175 1.82 0.0320 
STAT4 signal transducer and activator of transcription 4 XM 001082561 1.65 0.0420 
RELN reel in XM 001087819 1.46 0.0336 
ADAM17 ADAM metallopeptidase domain 17 XM 002799139 1.29 0.0073 
GABBR1 gamma-aminobutyric acid (GABA) B receptor, 1 XM 001097474 -1.39 0.0389 
.j:::.. BDNF brain-derived neurotrophic factor XM 001089568 -1.82 0.0076 
CX> ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) XM 001105246 -1.99 0.0045 
IPL Subcortical White Matter 
LIF leukemia inhibitory factor-like XM 001108593 3.38 0.0147 (LOC715456) 
TN Fa tumor necrosis factor NM_001047149 2.35 0.0076 
NGFR nerve growth factor receptor XM_001 090039 2.14 0.0182 
GADD45G growth arrest and DNA-damage-inducible, gamma XM_001091127 1.85 0.0014 
GMFG glia maturation factor gamma-like XM 001085983 1.82 0.0026 (LOC697397) 
CREB1 cAMP responsive element binding protein 1 XM 001107192 -1.39 0.0385 
BDNF brain-derived neurotrophic factor XM 001089568 -1.78 0.0348 
* p-value uncorrected for multiple comparisons 
Figure 1: Relative Gene Expression in the IPL Cortical Grey Matter versus Age. 
(A) BDNF (B) NTRK2 and (C) ADAM19 were all standardized to the expression 
of 18S rRNA in 27 animals. There are significant decreases with age in the gene 
expression of BDNF and ADAM19 in the cortical grey matter. **p<0.01, 
#p<0.001. 
49 
A 
B 
c 
BDNF IPL Grey Matter 
mRNA Expression 
2
·
5 #p = 0.0003 
r=-0 .641 
n = 27 
5 10 15 20 25 30 35 
Age (years) 
NTRK2 IPL Grey Matter 
mRNA Expression 
5 10 15 20 25 30 35 
Age (years) 
ADAM191PL Grey Matter 
mRNA Expression 
**p = 0.0056 
r=-0.519 
n = 27 
• ~ . 
...... 
• 
• • ..., .. .......: 
• 
5 10 15 20 25 30 35 
Age (years) 
50 
Figure 2: Relative Gene Expression in the IPL Subcortical White Matter versus 
Age. (A) BDNF standardized to 18S rRNA 27 animals, (B) NGFR standardized 
to RPL 13A in 26 animals (AM079x did not amplify), (C) NTRK2 standardized to 
18S rRNA in 26 animals (AM1 07b did not amplify) and (D) ADAM19 standardized 
to 18S rRNA in 27 animals. There is a significant increase in NGFR gene 
expression with age. *p<0.05. 
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Figure 3: IPL Grey Matter Protein Expression versus Age. The levels of (A) 
proBDNF, (B) mature BDNF and (C) TrkB full length (FL) and truncated {TR) 
forms standardized to r3-tubulin. Representative blots are shown for each 
antibody. There is a significant change with age in the expression of proBDNF. 
N=27, *p<0.05. 
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Figure 4: IPL White Matter Protein Expression versus Age. The levels of (A) 
mature BDNF, (B) proBDNF (C) NGFR and (D) TrkB full length (FL) and 
truncated (TR) forms standardized to myelin oligodendrocyte glycoprotein (MOG) 
are shown. Representative blots for each antibody are below the graph. There 
are no significant changes in any of the proteins with age in the subcortical white 
matter. N=27. 
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CHAPTER Ill 
Altered proBDNF Immunoreactivity with Age in the Inferior Parietal Lobule 
but not the Hippocampus of the Rhesus Monkey 
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Introduction 
In the mammalian brain there are four closely related neurotrophins 
consisting of nerve growth factor (NGF), brain-derived neurotrophic factor 
(BDNF), neurotrophin 3 (NT-3) and neurotrophin 4/5 (NT-4/5). Brain-derived 
neurotrophic factor (BDNF) is the most prevalent neurotrophic factor in the brain 
and is important for the growth, survival and differentiation of neurons (Mufson et 
al., 1999; Poo, 2001; Lu et al., 2005). In addition, BDNF is important for synaptic 
plasticity and is necessary for long term potentiation (L TP) in the hippocampus 
and development and maintenance of the dendritic tree of cortical neurons 
(Gorski et al., 2003; Sun et al., 2012). 
Like all of the neurotrophins, BDNF is synthesized as a propeptide 
(proBDNF). While proBDNF was originally believed to be an intermediate step in 
the formation of mature BDNF (mBDNF), evidence that it is a biologically relevant 
molecule in its own right is increasing. First, proBDNF can be cleaved both 
intracellularly by turin in the Golgi apparatus (Seidah et al., 1996; Mowla et al., 
1999; Chao, 2003; Greenberg et al., 2009) and extracellularly by tissue 
plasminogen activator (tPA) activated plasmin (Pang et al., 2004; Pang and Lu, 
2004; Gray and Ellis, 2008; Nagappan et al., 2009) as well as by 
metalloproteinases (Chao and Bothwell, 2002; Keifer et al., 2009). In addition to 
the presence of extracellular cleavage enzymes, proBDNF can be released from 
neurons (Yang et al., 2009) and signal through the p75 nerve growth factor 
receptor to induce long-term depression (L TO) in hippocampal neurons (Woo et 
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al., 2005). The released proBDNF can then be cleaved to mBDNF or it can be 
internalized by the perineuronal astrocytes for recycling and future release 
(Bergami et al., 2008). 
The loss of neurotrophins has been studied as a potential link to age 
related cognitive decline due to the role of BDNF in synaptic maintenance and 
plasticity (Poo, 2001 ). However, the results in aging have been mixed with 
studies finding increases, decreases or no change in BDNF protein levels with 
age in both the hippocampus and various cortical regions depending on the 
species and ages studied (reviewed in (Pang and Lu, 2004; Tapia-Arancibia et 
al., 2008)). Studies utilizing western blot analysis to distinguish between 
proBDNF and mBDNF report that the level of proBDNF was selectively 
decreased in the cortex of the aged rat with no age-related changes in mBDNF 
(Perovic et al., 2012). In the hippocampus, reports demonstrate proBDNF 
increases with age but disagree over whether there are alterations in mBDNF 
levels (Silhol et al., 2007; Perovic et al., 2012). In the inferior parietal lobule of the 
rhesus monkey, levels of proBDNF were decreased with age while there was no 
age-related change in mBDNF (previous chapter). 
Studies using immunohistochemistry have primarily focused , on the 
identification of areas that express total BDNF (Conner et al., 1997; Connor et 
al., 1997; Hayashi et al. , 2001; Zhang et al., 2007), with only one study focusing 
on proBDNF (Zhou et al., 2004). However, since proBDNF seems to be the 
vulnerable species with age, especially in the cortex, the present study is focused 
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on proBDNF immunoreactivity in the inferior parietal lobule (IPL) and the 
hippocampus. Since these brain regions are vulnerable to changes in aging 
(Burke and Barnes, 2006; Grieve et al., 2007; Kennedy and Raz, 2009), the goal 
was to determine if there are changes in proBDNF expression throughout the 
complete adult age range. 
Methods 
Subjects: A total of thirty-six adult rhesus monkeys (Macaca mulatta), 19 males 
and 17 females, ranging in age from 7.4-27.8 years were used in this study 
(Table 1 ). The monkeys were obtained and cared for in the same manner as 
described in chapter II. 
Tissue Preparation: The animals were deeply anesthetized and transcardially 
perfused with Krebs-Heinseleit buffer (6.41 mM Na2HP04, 1.67 mM NaH2C03 , 
137 mM NaCI, 2.68 mM KCI, 5.55 mM Glucose, 0.34 mM CaCh, 2.14 mM MgCh, 
pH 7.4) at 4°C prepared in RNase free conditions followed by 4% 
paraformaldehyde in phosphate buffer (0.1 M, pH 7.4) at 3rC. Fresh frozen 
samples were extracted from the left hemisphere while buffer was flowing but the 
right hemisphere was left intact. Following fixation, the right hemisphere of the 
brain was blocked in situ in the coronal plane to separate the occipital lobe. It 
was then removed, weighed and photographed and cryoprotected in a glycerol 
gradient before being flash frozen in a solution of 2-methybutane at -75°C 
(Rosene et al., 1986) and stored at -80°C until processing. Frozen sections were 
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cut in the coronal plane on a sliding microtome at 30 1-1m thickness and separated 
into 10 interrupted series that were stored in vials containing 15% glycerol (0.1 M 
phosphate buffer, pH 7.4) at -80°C until batch processed for 
immunohistochemistry. 
Immunohistochemical Processing 
Chromogenic Immunohistochemistry: Vials from all 36 animals consisting of 
one-eighth of a series (20-22 sections spaced at 2400 IJm intervals from frontal 
pole through parietal cortex) were warmed to room temperature and batch 
processed for proBDNF immunoreactivity to reduce procedural variance using a 
procedure adapted from Hoffman et al. (2008). All steps were done with 
agitation and were conducted at room temperature unless noted. Briefly, the 
free-floating sections were washed with 0.05M potassium phosphate buffered 
saline, pH 7.4 (KPBS) to remove the glycerol from the sections. They were post-
fixed in 4% Paraformaldehyde with 2.5% Acrolein (Sigma) for 15 minutes and 
then treated with a 1% sodium borohydride solution to remove free aldehydes 
remaining from the fixation. Endogenous peroxidases were quenched with 3% 
hydrogen peroxide in methanol for 1 hour and then the sections were rinsed with 
KPBS and then blocked in a solution of 10% normal goat serum (NGS) plus 
0.04% Triton X-1 00 in KPBS for 1 hour. Then, they were moved to the primary 
antibody solution containing KPBS, 0.4% Triton-X, 3% NGS, and the rabbit 
polyclonal anti-proBDNF primary antibody (1 :3000; ANT-006 (Lot AN-05); 
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Alomone Labs, Jerusalem, Israel) and incubated for one hour at room 
temperature followed by 48 hours at 4 °C. 
After incubation in the primary antibody, the sections were washed in 
KPBS and then placed in the solution of biotinylated goat anti-rabbit lgG 
secondary antibody (1 :600; BA-1 000; Vector Laboratories, Burlingame, CA), 
0.4% Triton-X, and 3% NGS in KPBS for 2 hours. Sections were then rinsed in 
KPBS and incubated in a peroxidase-conjugated avidin-biotin-complex 
(VECTASTAIN Elite ABC kit; PK-6100; Vector Laboratories, Burlingame, CA). 
The sections were rinsed in KPBS then 0.175M sodium acetate to remove the 
salt from the tissue. The secondary antibody was visualized by exposure to a 
0.02% 3,3'-diaminobenzidine tetrahydrocholride (DAB; 05905; Sigma-Aldrich, St. 
Louis, MO) solution containing 2.5% nickel (II) sulfate hexahydrate, 0.0025% 
hydrogen peroxide in 0.175M sodium acetate (Ni-DAB) for 15 minutes. The 
sections were then mounted on gelatin subbed slides and air dried for 24 hours, 
dehydrated in a graded alcohol series, cleared in xylenes, and coverslipped with 
Permount (Fisher Scientific). Controls were run in parallel including the 
exclusion of the primary antibody and preabsorption of the proBDNF antibody 
(1 :3000) with control antigen (1: 1500; AG-02; Alomone Labs, Jerusalem, Israel), 
a 80-fold molar excess of the peptide to the lgG. No staining was visible in either 
of the control conditions (Figure 6). All sections were then blinded for analysis. 
Fluorescent Immunohistochemistry: One vial from a subset of the 16 rhesus 
monkeys, 8 males and 8 females (identified in Table 3), was warmed to room 
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temperature and the IPL was dissected out of the sections and mounted on 
slides. Sections were dried overnight and boundaries were drawn around the 
sections using lmmEdge Hydrophobic Barrier Pen (Vector Laboratories, 
Burlingame, CA) to contain solutions. Sections were rinsed in 0.05 M Tris 
Buffered Saline (TBS) and blocked for one hour in a solution of 10% NGS and 
0.04% Triton X-100 in TBS. Sections were then incubated in the primary antibody 
solution of TBS, 0.4% Triton-X, 3% NGS, the rabbit polyclonal anti-proBDNF 
primary antibody (1 :200; ANT-006 (Lot AN-05); Alomone Labs, Jerusalem, 
Israel), the mouse monoclonal anti-microtubule associated protein (MAP2) 
(1 :500; MAB347; Millipore, Temecula, CA) and the rat monoclonal anti-glial 
fibrillary acidic protein (GFAP) (1 :1 000; 13-0300 (clone 2.2B1 0); Invitrogen, 
Camarillo, CA) for 1 hour at room temperature followed by 48 hours at 4°C in a 
humidified chamber. The slides were then rinsed in TBS and incubated in the 
secondary antibody solution of TBS, 0.4% Triton-X, 3% NGS, Alexa568 goat 
anti-rabbit lgG (1 :500; A-11 011; Molecular Probes, Carlsbad, CA), Alexa647 goat 
anti-mouse lgG (1 :200; A-21235; Molecular Probes, Carlsbad, CA), and 
Alexa488 goat anti-rat lgG (1 :500; A-11006; Molecular Probes, Carlsbad, CA) for 
2 hours at room temperature in a humidified chamber. Sections were washed in 
TBS and the lipofuscin autofluorescence was quenched using the 
Autofluorescence Eliminator Reagent (2160; Millipore, Temecula, CA) and 
coverslipped using antifading polyvinyl alcohol mounting medium with DABCO 
(10981; Sigma-Aldrich, St. Louis, MO). Controls omitting the primary antibodies 
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and preabsorption of the proBDNF antibody 1:1 (by weight) with the control 
antigen (AG-02; Alomone Labs, Jerusalem, Israel) were run in parallel and no 
staining was observed. 
Region of Interest: The inferior parietal lobule (IPL) was assessed for the 
number of cell bodies and puncta positive for proBDNF immunoreactivity as well 
as for total optical density of reaction product. The IPL was identified as the area 
of the cortex where both the intraparietal sulcus and the lateral fissure were both 
present in the section (Figure 5). For the optical density measurements, the 
subcortical white matter within the gyrus was also measured in addition to the 
cortical grey matter. In addition, the optical density of proBDNF was measured 
throughout the body of the hippocampus. For the analysis, the hippocampus 
was divided into six subregions; dentate gyrus granule cell layer (DG GCL), 
dentate gyrus molecular layer (DG ML), hilus, CA3 (cornu ammon is 3), CA 1 and 
the molecular layer of CA3 and CA 1 (ML). 
Image Analysis 
Cell Counts: The grey matter of the inferior parietal lobule was outlined using a 
Nikon 4X Plan objective and the Stereo Investigator program (version 9.14.3; 
MBF Biosciences, Williston, VT) on a Nikon Eclipse E600 microscope equipped 
with a LEP motorized stage and a MBF CX9000 digital camera. The systematic 
random sampling (SRS) Layout was generated in Stereo Investigator (sampling 
frame 100 x 100 IJm; grid size 1000 x 1000 IJm) and the "acquire SRS image 
series" function was used to generate images with a Nikon 1 OOX Plan Fluor oil 
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objective with a 5 second delay between image acquisitions for manual 
adjustment of focus. The images were obtained as 8-bit grayscale images 
(Figure 7 A). Using lmageJ software (version 1.45s, National Institutes of Health, 
http://imagej.nih.gov/ij) the brightness and contrast were enhanced (Figure 78), 
and the threshold applied (Figure ?C) equally for all images from all cases. The 
number of puncta and somata were determined by lmageJ using area exclusion 
parameters (Figures ?D-F: somata - 3,000-180,000 pixels2, puncta - 20-800 
pixels2 , and total - no size exclusions). Data were expressed as the number of 
particles per 1 001Jm2 of area sampled. 
Optical Density: Photomontages of the entire region of interest (the IPL and 
hippocampus) were obtained using Nikon 20X Plan Fluor on a Nikon E600 
microscope with a Prior H101A motorized XYZ stage and a Qlmaging Retiga 
13058 (OEM Fast Color 12-bit) digital camera controlled by the Surveyor 
program (version 6.1.0.3, Objective Imaging Ltd, Cambridge UK). The generated 
images were obtained with the same parameters for all animals: IPL images 
were obtained with an exposure time of 5301-Js and the hippocampus at 8001-Js 
(Figure SA and 8C). These images were opened in lmageJ and contours drawn 
around the regions of interest (ROI) and saved using the ROI manager. The 
images were then transformed to 8-bit and using the Uncalibrated Optical 
Density (OD) calibration in lmageJ, the OD inside of the contours was measured 
(Figure 88 and 80). No changes were made to the brightness or contrast of the 
images. 
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Confocal Microscopy: Fluorescence immunohistochemistry was assessed 
using Laser Scanning Confocal Microscopy on a Zeiss LSM71 0 confocal system 
(Carl Zeiss Microimaging). Three z-stacks with 0.51Jm spacing between images 
taken were taken randomly in the IPL grey matter from each of the subjects using 
a Plan-Apochromat 63X oil objective. The stacks of images were reconstructed 
using lmageJ and fraction of positively correlated pixels (lcorr) within the z-stacks 
of proBDNF with MAP2 and GFAP was measured using the colocalization 
colormap lmageJ plugin (Jaskolski et al., 2005). 
Statistics: Pearson's correlations were run to determine if there was an effect of 
age on the density of proBDNF positive cell bodies and puncta and the optical 
density measurements in the IPL grey matter, subcortical white matter and 
subregions of the hippocampus. In addition, student's t-tests were performed to 
determine if there was an effect of sex on any of the measurements. Statistical 
significance was set at a p<0.05 for two-tailed analysis for all tests using Prism 
(version 6; GraphPad Software Inc). 
Results: 
proBDNF Immunoreactivity in the Inferior Parietal Lobule 
The density of proBDNF immunoreactivity was calculated based on the number 
of particles of a given size that reached threshold divided by the area of the IPL 
analyzed. The somata were defined as particles with a diameter between 3.9 
and 30.3 IJm. Results demonstrated a significant increase with age in the density 
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of somata in the IPL with age (r=0.421, p=0.011, Figure 9A). The small puncta, 
were defined by a diameter of approximately 0.32 - 2.02 1Jm. Results 
demonstrated no significant linear relationship with age (r=-0.025, p=0.88, Figure 
98). There was no significant relationship to age in the density of pro8DNF 
immunoreactivity when size exclusions were removed (r=-0.045, p=0.78, Figure 
9C). Furthermore, the area of the regions of interest (IPL and hippocampus) 
analyzed did not change with age (data not shown). 
It is important to note that the threshold method excluded diffuse staining 
that was present in the neuropil and was often unable to distinguish between 
closely positioned small puncta. To evaluate the possible relationship of total 
proBDNF immunoreactivity to age, the optical density was measured. The 
results demonstrated a significant decrease in pro8DNF optical .density with age 
in the grey matter (r=-0.335, p=0.045, Figure 1 OA) and no change in the 
subcortical white matter (r=0.276, p=0.1 03, Figure 1 08). 
proBDNF Immunoreactivity in the Hippocampus 
To be able to determine if the change with age in pro8DNF is specific to certain 
cortical regions or representative of a global change in the brain, pro8DNF 
immunoreactivity was measured in the subregions of the hippocampus. Since in 
the IPL the optical density gave the most complete picture of the pro8DNF 
immunoreactivity, it was chosen for the analysis of the hippocampus. The 
hippocampus was divided into 6 subregions for analysis: DG GCL, DG ML, hilus, 
CA3, CA1, and ML. As shown in Figure 11, there was no change in pro8DNF 
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optical density with age in any of the hippocampal subregions: DG GCL (r=-
0.077, p=0.66, Figure 11A), DG ML (r=-0.086, p=0.62, Figure 11 B), hilus (r=-
0.087, p=0.61, Figure 11 C), CA3 (r=-0.092, p=0.59, Figure 11 D), CA 1 (r=-0.049, 
p=0.77, Figure 11E), and ML (r=-0.143, p=0.41, Figure 11F). 
Effect of sex on proBDNF Immunoreactivity 
Since both males and females were used in this study, the relationship between 
proBDNF and sex was examined. In the IPL, there were no gender differences 
in any of the parameters measured (Figure 12). However, in the hippocampus 
the females had significantly higher proBDNF optical density than the males in 
each of the subregions analyzed (Figure 13). Since there were gender 
differences, the relationship of proBDNF with age was examined within each sex. 
While the correlation between the level of proBDNF and age was stronger in the 
females than the males, this did not reach significance with the group sizes of 17 
females and 19 males (Figure 14). The optical density of proBDNF has the 
strongest correlations with age in the dentate gyrus granule cell layer (r=-0.450; 
p=0.069; Figure 14A) and the molecular layer of CA1 and CA3 (r=-0.431; 
p=0.085; Figure 14F) of the female rhesus monkey. 
Statistical outliers: 
There are two middle age animals, 19.0 and 19.7 year old males, that have low 
proBDNF immunoreactivity in the six hippocampal subregions. However, the 
level of proBDNF expression in these two subjects was not outside the spread of 
the other subjects for any of the measures in the I PL. In addition, the removal of 
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these two subjects from analysis does not alter the statistical results and so no 
data points were removed from the analysis. · 
Cell Type Expression of proBDNF 
To be able to determine what cell types could account for the alterations in 
proBDNF expression, fluorescent immunohistochemistry was utilized. The 
punctate staining of proBDNF is visible in both the MAP2 positive dendrites as 
well as GFAP positive processes in the IPL (Figure 15). In addition, the somal 
expression is primarily MAP2 positive neurons (Figures 16A and 168), although 
there are GFAP positive astrocytes (Figures 16C and 160) that have proBDNF 
co-localization. The degree of colocalization of proBDNF with MAP2 and GFAP 
was measured to determine if there was an age related change in the localization 
of proBDNF. In the grey matter of the IPL, colocalization was determined by the 
fraction of pixels in the z-stack that are positively correlated between the two 
markers (lcorr). There were significantly fewer pixels that were colocalized 
between proBDNF and MAP2 in the aged (22 years of age and older) compared 
to the young (less than 13 years of age) (p=0.0011; Figure 16E). In comparison, 
there was no change in the lcorr of proBDNF and GFAP pixels between the young 
and aged (p=0.39; Figure 16F). There were no gender differences in the 
colocalization of proBDNF with either MAP2 or GFAP in the IPL (data not 
shown). In addition, the fluorescent immunohistochemistry clearly shows the 
shift of proBDNF distribution in the neuron, where the aged animals have much 
more in the soma and less in the dendrites as seen in the colocalization with 
69 
MAP2 (Figure 16A and 168) than the young animals. The level of colocalization 
is higher in the MAP2 positive neurons than in the GFAP positive astrocytes 
indicating higher expression levels in neurons than glial cells. 
Discussion: 
Staining Pattern 
The expression pattern of proBDNF staining observed in the brain was 
consistent with previously published reports of both BDNF and proBDNF. 
Furthermore, the loss of signal when the antibody was pre-absorbed with the 
control antigen confirms that the antibody is specific for proBDNF. In the cortex, 
staining of cell bodies is visible with the apical dendrite stained in some of the 
pyramidal cells. The staining pattern is similar to those described for both 
proBDNF and total BDNF (Zhou et al., 2004; Zhang et al., 2007). The cell body 
staining in the cortex was primarily in layers 11/11 and layers VNI with sparse 
staining in layer IV. This pattern has been described at both the mRNA and 
protein levels for BDNF in the rat, monkey and human cortex (Huntley et al., 
1992; Conner et al., 1997; Webster et al., 2002; 2006). 
A smaller extrasomal punctate stain is also visible throughout the cortex. 
Previous studies have also reported punctate staining particularly in dendrites, 
axons, nerve terminals and glial cells (Conner et al., 1997; Connor et al., 1997; 
Zhou et al., 2004; Zhang et al., 2004; Bergami et al., 2008; Matsuda et al., 2009). 
This punctate stain is also visible in the fluorescently stained sections, indicating 
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this is a true representation of proBDNF in the tissue and not an artifact of the Ni-
DAB processing. 
In the hippocampus, there was staining in all of the subregions in high 
levels, with the highest levels of expression in the dentate gyrus and CA 1. The 
staining is visible in both dentate granule cells and pyramidal cells in regions CA3 
and CA1. The pyramidal cells have well defined staining in their dendrites. This 
cell type expression has been described previously (Conner et al., 1997; Connor 
et al., 1997; Kawamoto et al., 1999; Dieni et al., 2012). The small punctate stain 
visible in the IPL was also visible in all of the regions examined except the 
granule cell layer of the dentate gyrus, where the cells are packed together 
tightly. Additionally, the mossy fibers extending from the dentate gyrus to CA3 
have high levels of proBDNF expression and are visible in all sections, as has 
been reported (Danzer and McNamara, 2004 ). All together the consistency in 
the staining pattern with previous reports indicates the proBDNF staining in the 
present study is specific. 
Regional Differences in proBDNF Expression 
The levels of proBDNF are varied in the different brain regions, with the 
level in the hippocampus higher than in the IPL. There is also proBDNF 
expression in the subcortical white matter although this is at a much lower level 
than in the cortex. 
The optical density measurements, to quantify the immunoreactivity of 
proBDNF, were the method capable of capturing all of the staining instead of the 
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counts. The decrease in the immunohistochemical density in the cortical grey 
matter of the IPL is the same as the decrease by western blot in the aging rat 
cortex (Perovic et al., 2012) and the IPL of the aging rhesus monkey 
(unpublished). The levels of proBDNF are also significantly decreased in the 
parietal cortex in Alzheimer's disease (Michalski and Fahnestock, 2003; Peng et 
al., 2005). When trying to account for where the change in the protein was 
occurring, in the cell body or the extrasomal punctate staining, the overall 
decrease in the protein was not captured, as there was no change in the number 
of proBDNF positive puncta or total proBDNF immunoreactivity. However, the 
increase in the number of cell bodies expressing proBDNF in the IPL was a 
surprising result. This measurement captures the number of cells expressing 
proBDNF but not the amount of protein in the cell body. This increase can be 
explained by either an increase in the number of cells expressing proBDNF with 
age or decreased transport of the protein into the dendrites in the neurons. 
The presence and expression of proBDNF by glial cells is known (Zafra et 
al., 1992; Pechan et al., 1993; Lindholm et al., 1994; Elkabes et al., 1996; Wu et 
al., 2004). Astrocytes can internalize and recycle proBDNF (Bergami et al., 
2008) and also produce newly synthesized proBDNF particularly in response to 
brain injury (Sato et al., 2009). In addition, microglia express BDNF but at 
relatively low levels compared to other neurotrophic factors (Eikabes et al., 
1996). Since the main glial cell type expressing BDNF is the astrocyte, GFAP 
was chosen as the marker to help determine the cell type expressing proBDNF in 
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the IPL. The increase in the density of cell bodies expressing proBDNF with age 
could also be due to decreased transport of proBDNF out into the dendrites 
making the neuronal cell bodies more defined as the level increases. Visually, 
this appears to be the case where the cell bodies are easier to recognize in the 
older animals and therefore the threshold was more likely to recognize the cell 
body as a whole entity instead of the punctate stain. This decreased trafficking 
of the protein could be due to increased expression of sortilin with age (AI-Shawi 
et al., 2007; Terry et al. , 2011 ), the protein responsible for the trafficking, 
cleavage and degradation of proBDNF in the endosome (Egan et al., 2003; Chen 
et al., 2004; Evans et al., 2011 ). The increase in sortilin would traffic the 
proBDN F to the regulated secretory pathway versus the constitutive release 
pathway where the protein is trafficked to the synapse for activity dependent 
release (Chen et al., 2005). In addition, the overall loss of proBDNF without 
change in mBDNF can also be due to sortilin dependent lysosomal degradation 
where when bound to sortilin when the cytoplasmic tail is cleaved by the alpha 
secretase A disintigrin and metalloproteinase 10 (ADAM1 0) signals lysosomal 
degradation. While little is known about the levels of ADAM10 in normal aging, 
studies suggest that the level of the protein increases in neurons and there is no 
change in the activity with age (Bernstein et al. , 2003; Nistor et al., 2007; Endres 
and Fahrenholz, 2012). Therefore additional proBDNF binding to sortilin with age 
would lead to increased shuttling of the protein to the lysosome for degradation. 
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Difference in proBDNF Expression Between Males and Females 
While many of the previous studies of BDNF expression in animal models 
utilize only males, this study examined the expression levels in both males and 
females. In the sample of rhesus monkeys analyzed in this study, there was no 
difference between males and females in the IPL. However, there was between 
a 1.16 and 1.25 fold higher level of proBDNF expression in females compared to 
males in each of the six subregions of the hippocampus analyzed. Differences in 
BDNF expression between the sexes have been reported in humans where 
females have significantly higher BDNF in CSF and plasma (Lommatzsch et al., 
2005; Komulainen et al., 2008; Li et al., 2009; Driscoll et al., 2012), but 
interestingly, there is no gender difference in proBDNF expression in the parietal 
cortex (Michalski and Fahnestock, 2003; Peng et al., 2005). 
The levels of BDNF are responsive to estrogen levels in the brain, with the 
hippocampus particularly sensitive whi le many cortical regions including the 
parietal cortex have little response to estrogen replacement (Singh et al., 1995; 
Gibbs, 1998; 1999). This responsiveness is potentially due to the colocalization 
of estrogen receptors in BDNF expressing neurons and the ability of the estrogen 
receptor to bind to the BDNF gene sequence (Toran-AIIerand et al., 1992; 
Miranda et al., 1993; Singh et al., 1995; Sohrabji and Lewis, 2006). Estrogen 
receptors are not ubiquitously expressed in the brain and while the hippocampus 
has high expression of the receptors, the parietal cortex has very low levels of 
estrogen receptor expression (Mitra et al., 2003; Scharfman and Maclusky, 
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2005; 2006). This discrepancy in localization of estrogen receptors may explain 
why there is a difference in proBDNF expression between males and females in 
the hippocampus but not the I PL. 
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Table 3: Immunohistochemistry Subject Data 
ID AGE SEX Source Perfusate Hemisphere Experiment (years} Used 
AM222 7.4 M YNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM230 7.5 M YNPRC Krebs+4% PFA Right NiDAB 
AM198 7.8 F YNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM227HL 7.8 M YNPRC Krebs+4% PFA Right NiDAB 
AM218 8.0 M YNPRC Krebs+4% PFA Right NiDAB 
AM280 8.1 M YNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM229HL 8.3 M TNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM289 9.0 M YNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM255 9.5 F TPC Krebs+4% PFA Right NiDAB+Fiuor 
AM202 10.3 F YNPRC Krebs+4% PFA Right NiDAB 
AM254 11.4 F YNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM195 12.1 F YNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM278 15.3 F YNPRC Krebs+4% PFA Right NiDAB 
AM288 16.0 M YNPRC Krebs+4% PFA Right NiDAB 
AM215H 16.6 M YNPRC Krebs+4% PFA Right NiDAB 
AM257 17.6 F YNPRC Krebs+4% PFA Right NiDAB 
AM250 18.0 F TPC Krebs+4% PFA Right NiDAB 
AM190 18.0 F YNPRC Krebs+4% PFA Right NiDAB 
AM274 18.3 M YNPRC Krebs+4% PFA Right NiDAB 
AM253 18.4 F YNPRC Krebs+4% PFA Right NiDAB 
AM233H 19.0 M TNPRC Krebs+4% PFA Right NiDAB 
AM216H 19.7 M YNPRC Krebs+4% PFA Right NiDAB 
AM252 19.9 F YNPRC Krebs+4% PFA Right NiDAB 
AM226L 20.6 M YNPRC Krebs+4% PFA Right NiDAB 
AM256 20.7 F TPC Krebs+4% PFA Right NiDAB+Fiuor 
AM200 21.0 F YNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM208 22.7 M YNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM196 22.9 F YNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM236 22.9 M YNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM282 23.0 M YNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM234 23.5 F YNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM242 23.5 M YNPRC Krebs+4% PFA Right NiDAB 
AM243 24.4 M YNPRC Krebs+4% PFA Right NiDAB+Fiuor 
AM189 24.5 M TNPRC Krebs+4% PFA Right NiDAB 
AM220 25.7 F YNPRC Krebs+4% PFA Right NiDAB 
AM275 27.8 F TNPRC Krebs+4% PFA Right NiDAB 
Abbreviations: Krebs, Krebs Henseleit Buffer; 4%PFA, 4% Paraformaldehyde; YNPRC, 
Yerkes National Primate Research center, Atlanta, GA; TNPRC, Tulane National Primate 
Research Center, Covington, LA; TPC, Texas Primate Center, Alice, TX; NiDAB, Nickel 
DAB Immunohistochemistry; Fluor, Fluorescent Immunohistochemistry 
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Figure 5: Regions of Interest. (A) Lateral View of the rhesus monkey brain. The 
area of the IP analyzed is highlighted and the thick black line indicates the 
coronal blocking cut where the occipital lobe was removed from the brain . (8-D) 
Images of the proBDNF immunohistochemistry at 1X magnification taken with an 
exposure of 2001Js from an 8.3 year old male (B) an 18.3 year old male (C) and a 
22.9 year old male (D). The boundaries of the IPL, the intraparietal sulcus (IPS) 
and lateral fissure (LF) are labeled and the scale bars are 50001Jm. 
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Figure 6: proBDNF Immunohistochemistry Antibody Specificity. (A-C) 20X 
images of the IPL grey matter obtained at an exposure of 5301Js. (D-F) 20X 
images of the CA 1 region of the hippocampus obtained at an exposure of 8001JS. 
(G-1) 20X images of the dentate gyrus granule cell layer and hilus hippocampus 
obtained at an exposure of 8001JS. (J-L) 1 OOX images from the IPL grey matter 
obtained at an exposure of 6.35ms. (A,D,G,J) proBDNF antibody (B,E,H,K) 
preabsorption of proBDNF antibody with control antigen (C,F,I,L) omission of the 
primary antibody. Scale bars are 501Jm for 20X images and 251Jm for 1 OOX 
images. Images are all from a 7.4 year old male. 
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Figure 7: Image Processing Steps for IPL Counts of proBDNF Immunoreactivity. 
(A) Original 1 OOX 8-bit image (B) contrast enhanced image (C) threshold image. 
Examples of the counts from the analysis: (D) 9 proBDNF positive somata (E) 
898 proBDNF positive puncta and (F) 1478 total proBDNF positive 
immunoreactivity with the counted particles colored blue in each image. Any 
particle touching the edge of the image was excluded from analysis. Image size 
is 114.29 x 85.71 IJm. 
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Figure 8: Optical Density Regions of Interest. Images were obtained from the 
(A) IPL and (C) hippocampus at 20X magnification. Images were transformed to 
8-bit and outlines of the regions of interest were drawn. (B) Shows the outlines of 
the IPL GM, IPL WM and (D) shows the outlines of the hippocampal subregions: 
DG GCL, DG ML, Hilus, CA1, CA3, ML. Images are representative sections from 
an 8.3 year old male. Scale bar is 1 OOO!Jm. 
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Figure 9: Counts of proBDNF Immunoreactivity versus Age in the IPL. (A) 
Density of proBDNF positive somata sized 3000-30000 pixels2 (B) density of 
proBDNF positive puncta sized 20-800 pixels2 (C) density of proBDNF 
immunoreactivity with no size exclusions. There is significant increase in the 
density of proBDNF positive somata in the IPL grey matter. *p<O.OS. 
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Figure 10: Optical Density of proBDNF versus Age in the IPL. (A) Optical · 
density of the grey matter and (B) optical density of the subcortical white matter 
obtained from 20X images of the IPL obtained at an exposure of 5301JS for all 36 
subjects. There is a significant linear relationship between proBDNF optical 
density in the IPL grey matter but not subcortical white matter. *p<0.05. 
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Figure 11: Optical Density of proBDNF versus Age in the Subregions of the 
Hippocampus. (A) Dentate gyrus granule cell layer, (B) dentate gyrus molecular 
layer, (C) hilus, (D) CA3, (E) CA 1, and (D) molecular layer of CA3 and CA 1 
analyzed using images of the entire hippocampus obtained at 20X with an 
exposure time of 8001-Js for all 36 subjects. There are no significant linear 
relationships between proBDNF optical density and age in any of the subregions 
analyzed. 
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Figure 12: Effect of Sex on proBDNF Levels in the IPL. (A) Density of proBDNF 
positive somata (B) density of proBDNF positive puncta (C) total density of 
proBDNF immunoreactivity based on threshold images (D) optical density of IPL 
grey matter (E) optical density of IPL white matter. There are no significant 
differences in proBDNF expression between males and females in any of the 
measures based on two-tailed t-tests. Mean±SEM. 
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Figure 13: Sex Difference in proBDNF Optical Density in the Hippocampus. (A) 
Dentate gyrus granule cell layer (B) dentate gyrus molecular layer (C) hilus (D) 
CA3 (E) CA 1 (F) molecular layer of CA3 and CA 1. There are significant 
differences between proBDNF optical density in males and females in all 
subregions. Mean±SEM *p<0.05, #p<0.01. 
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Figure 14: Relationship of Age and Sex on proBDNF Immunoreactivity in the 
hippocampus. (A) Dentate gyrus granule cell layer (B) dentate gyrus molecular 
layer (C) hilus (D) CA3 (E) CA1 (F) molecular layer of CA3 and CA1. There are 
no significant correlations of proBDNF optical density with age in males or 
females. N= 19 males in black and 17 females in red. 
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Figure 15: Fluorescent Immunohistochemistry Images of proBDNF, MAP2 and 
GFAP in the IPL Grey Matter. (A-B) proBDNF alone (C-D) MAP2 alone (E-F) 
GFAP alone (G-H) merged image of all labels. A,C,E,G are from an 9.0 year old 
male and B,D,F,H are from a 22.9 year old male. Scale bar is 15~m. 
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Figure 16: Colocalization of proBDNF with MAP2 and GFAP in the IPL. (A-B) 
Colocalization heat maps for MAP2 (A-B) and GFAP (C-D) from a 9 year old 
male (A,C) and a 22 .9 year old male (B,D). The color bar is located beneath the 
images and the warm colors (red) indicate high colocalization and the cool colors 
(blues) indicate low colocalization. The average fraction of positively correlated 
pixels in each image (lcorr) is quantified for 8 young and 8 aged animals for 
proBDNF and MAP2 (E) and proBDNF and GFAP (F). Data is presented as 
mean±SEM, #p<0.01. Scale bar is 151Jm. 
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CHAPTER IV 
Conclusions and Future Directions 
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Contemporary studies of the normal aging monkey have demonstrated 
that age-related cognitive decline is not due to loss of neurons (Peters et al., 
1998; Roberts et al., 2012; Giannaris and Rosene, 2012; Freeman et al., 2008), 
but is significantly associated with damage to myelin sheaths and loss of axons 
in forebrain white matter (Peters and Sethares, 2002; 2003; Bowley et al., 201 0). 
While the cause of these myelin changes is not known, the studies in this thesis 
point to the heterogeneity of the aging process, with involvement of many 
different processes that together may contribute to this pathology. 
Summary of Results: 
While the white matter dysregulation is a key component to age-related cognitive 
decline, the studies of this thesis indicate that there are changes in the grey 
matter, which may contribute to the altered connectivity in the brain with age. A 
hypothetical model of how the changes that occur in the aging brain may cause 
the age-related cognitive decline is shown in Figure 17. If the myelin damage 
impacts the conduction of action potentials in the axon, failure of the action 
potential could lead to changes in dendritic morphology and spine loss as well as 
decreased neurotrophic feedback from the synapse. Together these factors 
could cause dying back of the axon and disconnection of neurons. The current 
studies looked at the expression of genes related to neuronal and axonal survival 
as well as axon-glial signaling. Table 4 summarizes the quantification of gene 
and protein expression that were confirmed from the original PCR array screen. 
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One gene that was identified as potentially important in the aging process is 
BDNF. It was the only gene that was altered at both the level of gene and 
protein expression with the precursor form of the protein affected by age while 
the mature form was unchanged in the cortex of the I PL. Hence, it was selected 
for further study. 
Table 4: Summary of Results 
IPL Grey Matter IPL White Matter Hippocampus 
• 
BDNF 
* 
BDNF 
• ADAM19 * 
ADAM19 
qPCR 
* 
NTRK2 
* 
NTRK2 
• NGFR • proBDNF .. proBDNF .. mBDNF 
* 
mBDNF 
Western Blot : TrkB full length * TrkB full length TrkB truncated .. TrkB truncated .. p75 full length 
• Optical Density * 
Optical Density .. Optical Density 
• Soma Density proBDNF 
* 
Punctate Density Immunohistochemistry 
• MAP2 Colocalization 
.. GFAP Colocalization 
J. Decrease with age; f Increase with age; *No change with age 
Brain-Derived Neurotrophic Factor: 
BDNF is an important target derived neurotrophic factor that is transported 
both anterogradely to the synapse and retrogradely from synapse (Altar et al., 
1997; Tongiorgi et al., 1997; Danzer and McNamara, 2004; Tongiorgi, 2008). The 
mature form of BDNF (cleaved from proBDNF) signals through the TrkB receptor 
and promotes neuronal survival and maintenance of the dendritic tree and axon 
(Mufson et al., 1999; Poo, 2001; Gorski et al., 2003; Matsunaga et al., 2004; 
Nakai et al., 2006). The precursor form of BDNF, proBDNF signals through the 
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p75 neurotrophin receptor and causes axonal retraction and spine loss (Wong et 
al., 2002; Wang et al., 2004; Koshimizu et al., 2009; Kotlyanskaya et al., 2013; 
Singh et al., 2008; Sun et al., 2012; Yoshii and Constantine-Paton, 2010). These 
opposite actions of the mature and pro forms of BDNF make it essential to 
identify the post-translation status of each form in the aging brain as total BDNF 
expression cannot differentiate between the state of the protein and the 
differences between the signaling of the two forms. For example, the specific 
reduction seen in proBDNF in the IPL grey matter may reflect a compensatory 
response that maintains levels of mBDNF in the face of decreased mRNA 
expression to be able to preserve spines and axons. Nevertheless, subtle local 
changes in the mature BDNF levels or signaling not captured in the current 
experiment may be responsible for the loss of spines and axons even as the 
neuron survives (Bowley et al., 2010; Peters et al., 1998; Dickstein et al., 2012). 
BDNF and Aging Brain Changes: 
BDNF and other neurotrophic factors may play a roll in the disconnection 
of the pyramidal neurons of the cortex through myelin damage and loss of the 
long projecting axons while the neuron is maintained by the short collateral axons 
(Figure 17). Loss of mBDNF signaling through the synapse may cause spine 
loss and retraction of the axon. While proBDNF is the species that is affected by 
age, the result is an increase in the ratio of mBDNF to proBDNF, a shift towards 
the survival signal. The current studies indicate, in aged rhesus monkey parietal 
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cortex, there is an alteration in the subcellular localization of the proBDNF, with 
the protein accumulating in the soma, while less accumulates in dendrites and 
axons even with a decrease in total proBDNF. As a result, proBDNF positive cell 
bodies are more prominent in the aged brain. This altered subcellular 
localization of proBDNF is one explanation that helps account for the increased 
number of proBDNF positive somata detected in the IPL. Trapping of the 
proBDNF in the soma may be due to a specific alteration in proBDNF transport 
out of the soma. Alternatively, it could represent a change in the transport of 
mBDNF as well. Since mBDNF is formed by the cleavage of proBDNF, 
antibodies directed to the c-terminal portion of the protein will recognize both 
isoforms of the protein while antibodies directed to the N-terminal pro-domain will 
recognize only proBDNF. To determine if mBDNF remains in the soma with age, 
it would be necessary to examine the colocalization of proBDNF positive sites 
with the total BDNF positive sites using the c-terminal BDNF antibody. The pixels 
of total BDNF not colocalized with proBDNF would identify mBDNF. Concurrent 
labeling with other neuronal markers such as NeuN (soma), MAP2 (dendrites 
and soma), SMI312 (axons) would enable localizatioin of the mBDNF within 
different compartments of the neuron. 
Both BDNF mRNA and protein are trafficked in the cell to the dendritic 
spines where the protein is released at the synapse in an activity dependent 
manner (An et al., 2008; Wu et al., 201 0; Yang et al., 2011 ). Impaired action 
potential conduction due to myelin damage would likely reduce activity 
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dependent release. If there were also altered transport of the protein to or from 
the synapse in the axons and dendrites with age, signaling resulting from the 
activity dependent regulated release of the protein would be decreased even 
more. Such a decrease in signaling could then underlie the observed reductions 
in spines (Duan, 2003; Dickstein et al., 2007; 2012), atrophy of dendrites (Cupp 
and Uemura, 1980; Luebke and Rosene, 2003; Dickstein et al., 2007) and loss of 
long axons (Peters and Sethares, 2002; Peters et al., 2010; Bowley et al., 2010) 
observed in the normal aging monkey brain. 
Regional Differences in proBDNF Expression: 
The requirements for BDNF signaling differ according to brain region. 
This is seen by the difference in the level of expression of proBDNF in the IPL 
and the hippocampus, where there are higher levels of expression of protein in 
the hippocampus. The higher level of expression in the hippocampus is may 
reflect the role of BDNF and proBDNF in regulating synaptic plasticity and 
L TP/L TD in the hippocampus (Figurov et al., 1996; Pang et al., 2004; Woo et al., 
2005; Danzer and McNamara, 2004). lnterstingly, an age-related loss of 
proBDNF was observed in the IPL but not the hippocampus, perhaps reflecting a 
"ceiling effect" for BDNF in the hippocampus. 
Additionally, sex differences in BDNF were evident in the hippocampus 
but not in the IPL. BDNF is estrogen responsive, with the estrogen receptor 
binding to the promoter region of BDNF (Sohrabji et al. , 1995; Sohrabji and 
106 
Lewis, 2006; Harte-Hargrove et al., 2013). The gender differences are likely due 
to the differential expression of estrogen receptors in these two brain regions, 
where the hippocampus has high levels of estrogen receptors while the 
expression of the estrogen receptor is low in the parietal cortex (Mitra et al., 
2003; Scharfman and Maclusky, 2005; 2006). ELISA in both CSF and plasma in 
humans have showed gender differences in total BDNF expression, with females 
having higher expression (Lommatzsch et al., 2005; Komulainen et al., 2008; Li 
et al., 2009; Driscoll et al., 2012). However, this is the first study to show gender 
differences in proBDNF expression. 
In considering these differences in expression with age and between 
sexes, one must also consider that the IPL is neocortical and the hippocampus is 
an allocortical structure reflecting huge differences across evolution. Hence, 
considerably more information is needed to determine whether the changes seen 
in the IPL with age are specific to this region or if the loss of proBDNF with age is 
a global phenomenon in the neocortex but not the allocortex. Similarly it will be 
important to determine if there are gender differences in other areas and how this 
rela.tes to estrogen receptor expression across regions. 
Studies in rodents have reported a specific loss of proBDNF with age in 
the cortex as a whole but found an increase in when the hippocampus alone was 
examined (Mufson et al., 1999; Perovic et al., 2012; Poo, 2001; Gorski et al., 
2003; Matsunaga et al., 2004; Nakai et al., 2006). The current study in Chapters 
II and Ill has shown an age-related loss in proBDNF in the IPL but no change in 
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the hippocampus, at least using immunohistochemistry as unfixed fresh frozen 
tissue was not available from the hippocampus for western blot analysis. The 
difference between these studies could reflect different age ranges used, as even 
in rodents the results of BDNF levels across the age range is dependent on the 
age range chosen, especially to represent the young group (Wong et al., 2002; 
Tapia-Arancibia et al., 2008; Wang et al., 2004; Koshimizu et al., 2009; 
Kotlyanskaya et al., 2013; Singh et al., 2008; Sun et al., 2012; Yoshii and 
Constantine-Paton, 201 0). Also, there could be differences in the sensitivity of 
the immunohistochemical assays in fixed tissue versus western blot 
quantification in unfixed tissue. It will be important in future experiments to 
examine cortical regions such as the prefrontal and cingulate cortices in addition 
to the IPL and the hippocampus to get a better idea as to possible regional 
differences in expression. 
Post-translational Processing and Degradation of proBDNF: 
While the studies in this thesis have shown that there is a specific 
decrease in proBDNF with age in the IPL, further work is needed to be able to 
reveal mechanisms underlying the specific loss of proBDNF while levels of 
mBDNF are preserved as well as why these aging changes were seen in the 
parietal neocortex and not the hippocampus. One potential cause of the 
decrease in the precursor without alteration to the mature form would be 
increased specific degradation of proBDNF. To be able to assess this question, 
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the level and activity of proteins and enzymes involved in the sorting, cleavage 
and degradation of proBDNF need to be examined in the aging rhesus monkey. 
The molecules that are involved in the sorting and degradation of proBDNF are 
sortilin, alpha secretase (ADAM10), furin and plasmin. Sortilin is important in the 
pathway as it stabilizes proBDNF so that furin is able to cleave it to form the 
mature protein in the secretory vesicles (Bowley et al., 2010; Lu et al., 2005; 
Peters et al., 1998; Yang et al., 2011; Dickstein et al., 2012). In addition, 
cleavage of the cytoplasmic tail of sortilin by ADAM10 directs the endosome to 
the lysosome for degradation (Figurov et al., 1996; Evans et al., 2011; Pang et 
al., 2004; Woo et al., 2005; Danzer and McNamara, 2004). Studies in mice and 
rats have shown that there may be age related increases in sortilin protein levels 
by western blot and immunohistochemistry in the prefrontal cortex, basal 
forebrain and hippocampus (AI-Shawi et al., 2008; Terry et al., 2011) and 
decreased activity of plasmin, the enzyme responsible for extracellular cleavage 
of proBDNF (Cacquevel et al., 2007). All of these are involved in the processing 
and degradation of proBDNF and would be important for the further 
understanding of the age-related changes that were found in this thesis. 
Future Directions: 
In addition to gaining further information about the processing of proBDNF 
with age, the studies in this thesis raise questions about the level of expression 
of other genes that were identified as potential targets on the PCR array in 
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Chapter II. Alterations in the expression of many of these genes with age could 
also be important for myelin pathology. Of these genes, several are of particular 
interest in regards to neuronal function and survival as well as myelination. 
Some of the genes that would be of interest but were not selected for 
confirmation are the alpha secretase (ADAM17), the growth arrest and DNA 
damage inducible gene (GADD45G) and a neuropoetic cytokine (LIF). 
ADAM Metallopeptidase Domain 17 (ADAM17): 
ADAM17 is the tumor necrosis factor alpha (TNFa) convertase enzyme, 
releasing the proinflammatory cytokine TNFa from the cell membrane and was 
upregulated in the cortex of the IPL (Black et al., 1997; Moss et al., 1997b). In 
addition, ADAM17 is part of both the regulated and constitutive a-secretase 
pathways and is involved in the processing of many proteins including cleavage 
of the c-terminal fragment of the p75 neurotrophin receptor and amyloid 
precursor protein (Buxbaum et al., 1998; Skeldal et al., 2011 ). 
Growth Arrest and DNA Damage Inducible, Gamma (GADD45G): 
GADD45G was upregulated in both the grey matter and the subcortical 
white matter of the IPL and is induced by environmental stress and DNA 
damage. It serves as a marker of the activation of the tumor suppressor protein, 
p53, to repair DNA damage or lead to apoptosis when the damage is unable to 
be repaired (Papathanasiou et al., 1991; Takekawa, 2000; Ying et al., 2005). 
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Leukemia Inhibitory Factor (LIF): 
One of the genes of most interest for future studies in relationship to the 
white matter damage and remyelination is Leukemia Inhibitory Factor (LIF). LIF 
is a member of the IL-6 superfamily and is a powerful neuropoetic cytokine that 
has been found to be expressed by astrocytes and microglia and increased 
following cortical injury (Banner et al., 1997). In models of multiple sclerosis, LIF 
limits demyelination and promotes survival of the oligodendrocytes following 
experimental autoimmune encephylomyelitis (Butzkueven et al., 2002; 2006; 
Slaets et al., 201 0). In addition, LIF enhances remyelination (Marriott et al., 
2008) and limits the production of proinflammatory cytokines (Hendriks et al., 
2008). In the hypothetical model (Figure 17), LIF would be involved in the white 
matter myelin changes, where age-related increases in expression would be 
involved in oligodendrocyte survival, differentiation and remyelination of the axon. 
LIF had the highest fold change on the PCR array and the confirmation of 
LIF expression was attempted in Chapter II. The primer and probe set was able 
to amplify the mRNA, but with the amount of starting RNA available for the 
experiment did not allow for proper amplification of the transcript in all of the 
subjects. With a starting concentration of RNA of 300ng, the amplification of LIF 
did not reach the level of detection in nine of the 12 animals under the age of 13 
years old. Amplification of the transcript was successful in all of the animals over 
19 years of age. Since the expression is very low in the young animals, much 
higher quantities of starting RNA would need to be used in the reaction to reliably 
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quantify expression in the white matter of the young rhesus monkey. 
Additionally, if the quantification of expression in the young is not possible, it may 
be necessary to shift the age range and study the expression more in the middle 
age and aged animals instead of the young adults. 
Conclusion: 
Understanding the cause of axonal loss and myelin dysregulation with 
normal aging is important for th~ development of treatments to prevent the 
pathology and cognitive loss present in normal aging, which affect the quality of 
life in the elderly. The studies of this thesis indicate that changes in the grey 
matter are important in aging, as the majority of the chages in expression found 
were in the cortex and not in the subcortical white matter. While white matter 
changes are the main neuropathology present in the aging brain, subtle changes 
to signaling in the cortex that may affect the white matter function cannot be 
ignored. In addition, the studies of this thesis point to an important role of brain-
derived neurotrophic factor and its precursor protein, proBDNF, in the aging 
rhesus monkey brain. 
Figure 17: Model of Cortical Disconnection with Age. The areas of vulnerability 
are highlighted to illustrate how myelin damage and axonal loss can cause the 
disconnection of cortical pyramidal neurons leading to age-related cognitive 
decline. Adapted from (Kohama et al., 2012). 
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